Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Adrenocortical carcinoma - current concepts and future perspectives

      ea0035eje1
    • European Journal of Endocrinology Prize Winner

      ea0035eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Did the hand, then, of the potter shake?

      ea0035gh1
    • Geoffrey Harris Prize Winner

      ea0035gh1biog
• Plenary Lectures
• • Genes, environment and endocrine disease
  • • Genetics, environment and endocrine diseases

      ea0035pl1
  • Advances in molecular pathogenesis of thyroid cancer therapeutic implications
  • • Advances in molecular pathogenesis thyroid cancer: therapeutic implications

      ea0035pl2
  • Good times, bad times: (patho)physiology of diurnal rhythms
  • • Good times, bad times: (patho)physiology of diurnal rhythms

      ea0035pl3
  • Islet transplantation
  • • Islet Transplantation Plenary 5 (Tuesday 6th May 2014)

      ea0035pl4
  • Simultaneous treatment of menopausal symptoms and prevention of breast cancer: Is it possible?
  • • Menopausal hormone therapy and breast cancer: evidence of promotion not causation from tumor kinetic models

      ea0035pl5
  • Hypothalamic inflammation cause or consequence of obesity?
  • • Hypothalamic inflammation: cause or consequence of obesity?

      ea0035pl6
  • Reproduction and energy metabolism, an ancestral balance to be preserved for women's health
  • • Abstract unavailable

      ea0035pl7
• Symposia
• • Endocrine changes and treatment needs in critically ill patients
  • • Thyroid dysfunction in critically ill patients: to treat or not to treat?

      ea0035s1.1
    • Adrenal (dys)function in critically ill patients

      ea0035s1.2
    • Abstract unavailable

      ea0035s1.3
  • Pituitary development from basic research to clinical practice
  • • Abstract unavailable

      ea0035s2.1
    • Abstract unavailable

      ea0035s2.2
    • Management of adult patients with disorders of pituitary development

      ea0035s2.3
  • News from thyroid hormones: central transport, energy control and oxidative stress
  • • Neuro-glial functional coupling in deiodination mediated thyroid hormone signaling

      ea0035s3.1
    • Novel aspects of thyroid hormone transport in the mouse brain

      ea0035s3.2
    • Oxidative damage to macromolecules in the thyroid gland: experimental evidence

      ea0035s3.3
  • Endocrine Nurses Session 1: Craniopharyngioma
  • • Craniopharyngioma: challenges in the management of patients with craniopharyngioma

      ea0035s4.1
    • The role of the endocrine nurse in the long term care and treatment of patients post craniopharyngioma

      ea0035s4.2
    • Psychological aspects of living with a pituitary related condition

      ea0035s4.3
  • Obesity Beyond BMI
  • • Abstract unavailable

      ea0035s5.1
    • Relevance of body composition analysis

      ea0035s5.2
    • Are metabolically obese individuals are really healthy?

      ea0035s5.3
  • Focus on novel developments of PCOS conclusions from the PCOS Task Force
  • • Abstract unavailable

      ea0035s6.1
    • Diagnosis of PCOS

      ea0035s6.2
    • Focus on novel developments of PCOS: conclusions from the PCOS Task Force: treatment of PCOS

      ea0035s6.3
  • Nontumorous pituitary diseases
  • • Abstract unavailable

      ea0035s7.1
    • Unusual pituitary infections

      ea0035s7.2
    • Abstract unavailable

      ea0035s7.3
  • Membrane lipid composition and receptor function. Signalling and trafficking
  • • Membrane lipid composition and receptor function

      ea0035s8.1
    • Spatiotemporal control of endocytosis

      ea0035s8.2
    • Membrane dynamics in physiology and disease: PI3K signaling

      ea0035s8.3
  • EYES Session - Cold metabolic inflammation in obesity: ignored complication and treatment target?
  • • Introducing EYES: European Young Endocrine Scientists

      ea0035s9.1
    • Fertility: PCOS: metformin

      ea0035s9.2
    • The emerging landscape for nanomedicine in atherosclerosis

      ea0035s9.3
  • Difficulties in the treatment of Graves orbitopathy
  • • New therapeutic approach in Graves' orbitopathy

      ea0035s10.1
    • Radiotherapy in Graves' orbitopathy: current status

      ea0035s10.2
    • When should we perform orbital decompression

      ea0035s10.3
  • Long term outcome of cured pituitary patients
  • • Long-term outcome of 'cured' patients: acromegaly

      ea0035s11.1
    • Quality of life in patients with non-functioning pituitary adenomas

      ea0035s11.2
    • Abstract unavailable

      ea0035s11.3
  • Gut microbiota in diabetes and obesity
  • • Abstract unavailable

      ea0035s12.1
    • Fecal transplantation in obesity/type 2 diabetes Dr M Nieuwdorp

      ea0035s12.2
    • Functional interactions between diet, microbiota and host: effects on intestinal architecture and host nutrient absorption

      ea0035s12.3
  • Endocrine Nurse Session 3: Meet the Nurse Expert - Management of Endocrine Emergencies
  • • Abstract unavailable

      ea0035s13.1
    • Abstract unavailable

      ea0035s13.2
    • Abstract unavailable

      ea0035s13.3
  • Clinical outcome of medical intervention in Disorder of Sex Development (DSD)
  • • dsd-LIFE: clinical European outcome study of disorders of sex development

      ea0035s14.1
    • Consequences of the preservation of underdeveloped testes in adulthood

      ea0035s14.2
    • Developmental disruption of paracrine hormone regulation in the pathogenesis of germ cell neoplasms

      ea0035s14.3
  • Thromboembolism and contraception
  • • Epidemiology of sex steroid-related thromboembolism

      ea0035s15.1
    • Abstract unavailable

      ea0035s15.2
    • The view of the gynecologist on thromboemboembolism

      ea0035s15.3
  • Metformin: old dog, new tricks
  • • Abstract unavailable

      ea0035s16.1
    • Mechanisms of antitumoral activity of metformin in thyroid cancer

      ea0035s16.2
    • Antitumoral effects of metformin on cancer stem cells: identification of novel molecular targets

      ea0035s16.3
  • Cushings syndrome
  • • Mortality: still increased despite cure in Cushing's disease?

      ea0035s17.1
    • Abstract unavailable

      ea0035s17.2
    • Medical therapy for endogenous hypercortisolism

      ea0035s17.3
  • Endocrine disease during pregnancy
  • • Pituitary tumours during pregnancy

      ea0035s18.1
    • Pheochromocytoma/paraganglioma in pregnancy

      ea0035s18.2
    • Congenital adrenal hyperplasia in pregnancy

      ea0035s18.3
  • Osteoporosis - An update
  • • Paediatric osteoporosis

      ea0035s19.1
    • Denosumab: current perspectives

      ea0035s19.2
    • Abstract unavailable

      ea0035s19.3
  • New hormones and endocrine tissues
  • • FGF21, irisin and other novel players in endocrine metabolic regulation

      ea0035s20.1
    • Products of the ghrelin gene, their role in regulating [beta] cell and adipocyte function

      ea0035s20.2
    • The gut: a key organ coordinating the brain control of energy homeostasis

      ea0035s20.3
  • Dilemmas in hormonal replacements
  • • Abstract unavailable

      ea0035s21.1
    • Abstract unavailable

      ea0035s21.2
    • Dilemmas in hormonal replacements: can we offer GH replacement to patients with a history of malignancy?

      ea0035s21.3
  • Novel therapies for thyroid cancer
  • • Abstract unavailable

      ea0035s22.1
    • Limits of targeted therapies and future developments

      ea0035s22.2
    • Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

      ea0035s22.3
  • Neuroendocrine tumours
  • • Molecular pathogenesis of neuroendocrine tumours

      ea0035s23.1
    • Abstract unavailable

      ea0035s23.2
    • Abstract unavailable

      ea0035s23.3
  • Nutrient regulation of metabolism and endocrine systems
  • • Nutrient regulation of metabolism and endocrine systems: using low-carbohydrate/high-fat diets to dissect macronutrient effects on endocrine systems

      ea0035s24.1
    • Metabolic consequences of a high-fat diet on mouse models of GH action

      ea0035s24.2
    • Abstract unavailable

      ea0035s24.3
  • Gonadal hormones and obesity
  • • Gonadal hormones and obesity: estrogens and body weight

      ea0035s25.1
    • PCOS and obesity: unveiling the basic links

      ea0035s25.2
    • Perinatal androgen exposure and body weight fate

      ea0035s25.3
  • Pitfalls in hormone measurement
  • • Guidelines on GH/IGF1 measurement

      ea0035s26.1
    • Pitfalls in the measurement and interpretation of thyroid function tests

      ea0035s26.2
    • Advantages in the measurement of steroid hormones

      ea0035s26.3
  • Brown Adipose Tissue
  • • White, brown, and pink adipocytes: the extraordinary plasticity of the adipose organ

      ea0035s27.1
    • Abstract unavailable

      ea0035s27.2
    • Brown adipose tissue: the wholy grail of metabolic disease

      ea0035s27.3
  • Molecular pathophysiology for clinicians: receptor-related disorders
  • • Abstract unavailable

      ea0035s28.1
    • Disorders related to nuclear receptors

      ea0035s28.2
    • Disorders related to calcium-sensing receptor signalling

      ea0035s28.3
  • (1)
  • • Mediterranean diet in the prevention of cardiovascular disease

      ea0035s29.1
• Meet the Expert Sessions
• • (1)
  • • Abstract unavailable

      ea0035mte1
    • Abstract unavailable

      ea0035mte2
    • Premature ovarian insufficiency

      ea0035mte3
    • The zebrafish, a teleost model recapitulating the mammalian molecular events during endocrine development and function

      ea0035mte4
    • The Year in the Adrenals

      ea0035mte5
    • Abstract unavailable

      ea0035mte6
    • Therapeutic dilemmas in NETs

      ea0035mte7
    • Abstract unavailable

      ea0035mte8
    • Abstract unavailable

      ea0035mte9
    • Pituitary disorders and osteoporosis

      ea0035mte10
    • Abstract unavailable

      ea0035mte11
    • Abstract unavailable

      ea0035mte12
    • Pituitary apoplexy: diagnosis and management

      ea0035mte13
    • Real-time monitoring of GPCR signalling in living cells

      ea0035mte14
    • Abstract unavailable

      ea0035mte15
    • Postmenopausal hyperandrogenism

      ea0035mte16
    • FGF23 and phosphorus homeostasis: physiology and pathophysiology

      ea0035mte17
• Oral Communications
• • Thyroid clinical
  • • Esophagus motility in overt hypothyroidism

      ea0035oc1.1
    • Levothyroxine substitution in subclinical hypothyroidism: Does it have a beneficial effect on all-cause mortality?

      ea0035oc1.2
    • Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)

      ea0035oc1.3
    • Consequences of experimental hyperthyroidism on brain structure and function in humans

      ea0035oc1.4
    • rh-TSH (Thyrogen) aided radioiodine therapy in children and adolescents with DTC

      ea0035oc1.5
  • Adrenal clinical
  • • Armadillo repeat containing 5 gene (ARMC5) alterations in a large cohort of 98 ACTH-independant macronodular adrenal hyperplasia (AIMAH) patients: genotype/phenotype correlations.

      ea0035oc2.1
    • Constitutive activation of PRKACA in adrenal Cushing's syndrome

      ea0035oc2.2
    • Prognostic value of DNA methylation in adrenocortical carcinomas: an ENSAT study

      ea0035oc2.3
    • Detection of pheochromocytoma by enzyme immunoassay measurements of plasma metanephrines requires appropriately established upper cut-offs of reference intervals

      ea0035oc2.4
    • Treatment strategy and outcome with primary aldosteronism: a nationwide longitudinal cohort based study

      ea0035oc2.5
  • Neuroendocrinology & Signalling
  • • Constant intravenous infusion of kisspeptin-54 restores LH pulsatility in women with hypothalamic amenorrhoea

      ea0035oc3.1
    • Copeptin in the diagnosis and differential diagnosis of diabetes dnsipidus - the 'CoSIP-study'

      ea0035oc3.2
    • Evidence for interaction between the [beta]₂-adrenergic and the insulin receptor

      ea0035oc3.3
    • Role Of thyroid hormone receptor [beta] expression in lymphangiogenesis in breast carcinoma

      ea0035oc3.4
    • NTRK3 receptor expression is strictly associated with medullary thyroid cancer RET mutation status

      ea0035oc3.5
  • Diabetes and Obesity 1
  • • The lower postprandial glucose oxidation in nondiabetic carriers of risk variants of TCF7L2 gene

      ea0035oc4.1
    • Vildagliptin alone, and in half-dose combination with metformin, attenuates streptozotocin-induced diabetic nephropathy in high-fat fed heminephrectomized rats

      ea0035oc4.2
    • Importance of neuropeptide Y as a predictor of nephropathy in type 2 diabetic patients

      ea0035oc4.3
    • Endothelial progenitor Cells exhibit decreased function but increased numbers in overt type 2 diabetic nephropathy

      ea0035oc4.4
    • A comparison of lipoprotein associated phospholipase A2 and high sensitive C-reactive protein levels between diabetic and non-diabetic patients with coronary artery disease

      ea0035oc4.5
  • Adrenal & Thyroid
  • • Diagnostic and therapeutic outcome in ERCUSYN: Preliminary report in over 1000 patients

      ea0035oc5.1
    • Relationship between final height and cardiometabolic risk and quality of life in adults with congenital adrenal hyperplasia: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)

      ea0035oc5.2
    • Mitotane induces endoplasmic reticulum stress triggering apoptosis and decrease of steroid hormone synthesis

      ea0035oc5.3
    • MUC-1 - a novel preclinical model for adrenocortical carcinoma

      ea0035oc5.4
    • Validation of follicular thyroid cancer molecular classifier in fine-needle aspiration biopsy samples

      ea0035oc5.5
  • Bone, calcium & vitamin D
  • • Ucma as a direct common target of Runx2 and Osterix promotes osteoblast differentiation

      ea0035oc6.1
    • High spontaneous osteoclastogenesis in pediatric osteogenesis imperfecta patients receiving or not intravenous neridronate

      ea0035oc6.2
    • Hypoparathyroidism: The burden of illness and impact on patients' personal lives

      ea0035oc6.3
    • The REPEAT Study: An open-label clinical trial evaluating the safety and efficacy of recombinant human parathyroid hormone, rhPTH(1-84), for the treatment of hypoparathyroidism in hungary

      ea0035oc6.4
    • The effect of recombinant human parathyroid hormone, rhPTH(1-84), on vitamin D metabolism and phosphate homeostasis: Results from phase III 24-Week REPLACE and phase I clinical studies

      ea0035oc6.5
  • IGF-1 and Thyroid Basic
  • • GH induces chemoresistance in human endometrial cancer cell lines involving ERK 1/2 and PKCdelta

      ea0035oc7.1
    • The proposed molecular mechanism underlying isolated growth hormone deficiency (IGHD) caused by C53S mutation

      ea0035oc7.2
    • Targeting the insulin-like growth factor 1 (IGF1R) and insulin (IR) receptor with a dual IGF1R/IR inhibitor, OSI-906, to potentiate mTOR inhibitor effects in experimental models of hepatocellular carcinoma (HCC)

      ea0035oc7.3
    • Training MCT10 to transport thyroxine: Structure based targeted mutations in MCT10

      ea0035oc7.4
    • Direct triiodothyronine effects in brown adipocytes

      ea0035oc7.5
  • Pituitary clinical
  • • Metabolic improvement after treatment of acromeglay is determined by the increase of gynoid fat mass and the decrease of serum vaspin and IGF1

      ea0035oc8.1
    • Soluble [alpha]-Klotho - a new serum biomarker for the activity of acromegaly

      ea0035oc8.2
    • Assessment of atrial electromechanical delay in patients with acromegaly

      ea0035oc8.3
    • Normalization of urinary cortisol with the potent 11[beta]-hydroxylase inhibitor LCI699 in patients with Cushing's disease: 22-week, multicentre, open-label study

      ea0035oc8.4
    • The effects of glucocorticoid treatment on cognition in patients with secondary adrenal insufficiency - results from a RCT

      ea0035oc8.5
  • Reproduction
  • • High frequency of FGFR1 mutations in patients with congenital hypogonadotropic hypogonadism and split hand/foot malformation

      ea0035oc9.1
    • Tadalafil ameliorates metabolic syndrome-induced alterations in visceral adipose tissue and liver: an experimental study in the rabbit

      ea0035oc9.2
    • Late onset hypogonadism influences the endothelial function in men with coronary artery disease

      ea0035oc9.3
    • Kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatment

      ea0035oc9.4
    • IGF1 gene polymorphism in Polycystic Ovary Syndrome

      ea0035oc9.5
  • Endocrine Tumours
  • • Blood-borne and tissue microRNAs in adrenocortical tumours: affected pathways and diagnostic relevance

      ea0035oc10.1
    • The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF

      ea0035oc10.2
    • The NMU signaling controls cancer progression of human RL95-2 endometrial cancer cells through cell motility maintenance

      ea0035oc10.3
    • Mast cell interactions at tumour interface drive progression in human prostate cancer

      ea0035oc10.4
    • Molecular mechanisms underlying the unexpected promoting effects of mifepristone on murine testicular Leydig cell tumorigenesis

      ea0035oc10.5
  • Diabetes and Obesity 2
  • • Inhibition of cardiac dysfunction in diabetic mice by treatment with brain natriuretic peptide

      ea0035oc11.1
    • An audit of the management of inpatient glycaemia using point of care testing data at Manchester Royal Infirmary

      ea0035oc11.2
    • Improvement or stabilization of retinopathy and visual acuity after islet transplantation: a 5-year prospective study

      ea0035oc11.3
    • A novel adult human adipose stem cell model from inducible brown fat surrounding pheochromocytoma tumors

      ea0035oc11.4
    • Lipodystophic laminopathies are characterised by an increased intra/whole abdominal fat ratio with preserved fat/lean mass ratio and hypoleptinemia, in contrast with obese people, compared to controls

      ea0035oc11.5
  • Pituitary Basic
  • • Human AIP gene rescue lethality in a Drosophila melanogaster knockout model of AIP orthologue

      ea0035oc12.1
    • Differential in vitro response to octreotide and pasireotide in normal and tumoral primary pituitary cell cultures

      ea0035oc12.2
    • Detection of pituitary antibodies by immunofluorescence: Methodological approach and results in patients with pituitary diseases

      ea0035oc12.3
    • Identification and characterization of pituitary adenoma stem-like cells in human non functioning pituitary adenomas

      ea0035oc12.4
    • Does hypercortisolism of Cushing's syndrome affect telomere length?

      ea0035oc12.5
• Nurse Posters
• • (1)
  • • Level of knowledge about type I diabetes mellitus among nurses employed at endocrinological dispensaries

      ea0035n1
    • Radiation-induced multiple late complications after childhood acute lymphoblastic leukemia: A case report

      ea0035n2
    • Reduced psychological mental stress improved glycemic control in type 2 diabetic patients.

      ea0035n3
    • Adherence to treatment for chronic hypogonadism: the role of illness perceptions and depressive symptoms

      ea0035n4
    • Acromegaly patients' experiences of nursing

      ea0035n5
    • Effects of PRKAR1A mutations in behavior and brain function

      ea0035n6
    • The Nordic network for endocrine nurses (NNEN).

      ea0035n7
    • Application of international classification of functioning, disability and health to assess physical function in patients with diabetes Mellitus

      ea0035n8
• Poster Presentations
• • Adrenal cortex
  • • Which serum cortisol after high dose short synacthen test, 30 or 60 min?

      ea0035p1
    • Development of new improved derivatives of iodometomidate for the diagnosis of adrenocortical tumours and radiotherapy of adrenal carcinoma

      ea0035p2
    • Cardiovascular risk in Cushing's syndrome vs obesity

      ea0035p3
    • ACTH-secreting pheochromocytoma: case report

      ea0035p4
    • Are small adrenal incidentalomas solely a radiological finding?

      ea0035p5
    • An autopsy case of ectopic ACTH-secreting lung carcinoid with Cushing's syndrome

      ea0035p6
    • Favorable long-term outcome of bilateral adrenalectomy in Cushing's disease

      ea0035p7
    • Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma

      ea0035p8
    • Hormonal and clinical correlations in nonfunctional adrenal incidentalomas

      ea0035p9
    • Clinical, laboratory findings and results of therapy in patients with Cushing's syndrome

      ea0035p10
    • VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines

      ea0035p11
    • New drugs switching off Wnt/[beta]-catenin signaling in adrenocortical tumor cells

      ea0035p12
    • Effects of everolimus, nilotinib, imatinib and ZOL in combination with mitotane in monolayer and spheroids human adrenocortical tumor cell line

      ea0035p13
    • Two uncommon adrenal incidentalomas

      ea0035p14
    • Cushing's syndrome in women with polycystic ovary syndrome

      ea0035p15
    • Adrenal hormons substitution in MElas syndrome

      ea0035p16
    • Female to male gender identity disorder in a patient with non-classical congenital adrenal hyperplasia

      ea0035p17
    • Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the 'REDUCE*' randomized trial

      ea0035p18
    • Acute pasireotide suppression test in patients with Cushing's disease: a role in predicting long-term efficacy?

      ea0035p19
    • Measurement of serum total cortisol using HPLC coupled ESI-TOF mass spectrometry

      ea0035p20
    • Hypoaldosteronism post Conn's adenoma retroperitoneal adrenalectomy presenting with acute renal failure and hyperkalaemia requiring mineralocorticoid replacement

      ea0035p21
    • Hyponatremia as a predictor of in-hospital mortality

      ea0035p22
    • A case of an accessory spleen mimicking a nonfunctional incidentaloma

      ea0035p23
    • Bone mineral density, markers of bone remodeling, and quality of life in patients with Cushing's syndrome after 12 months of remission

      ea0035p24
    • Subclinical hypercortisolemia: who should be operated?

      ea0035p25
    • Recovery of the hypothalamo-pituitary adrenal axis following successful surgical treatment in various forms of Cushing's syndrome

      ea0035p26
    • A three generation family with low cortisol, CBG deficiency, chronic fatigue and pain, lipomatosis and behavioral alterations

      ea0035p27
    • Adrenal incidentaloma: current situation in Lithuania

      ea0035p28
    • The treatment with glucocorticoids in congenital adrenal hyperplasia: short- and long-term effects of the switch from conventional glucocorticoids to 'dual release' hydrocortisone on metabolic and hormonal profile

      ea0035p29
    • Development of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency

      ea0035p30
    • Postpartum adrenocortical deficiency: a case report

      ea0035p31
    • Relative adrenal insufficiency in acute ischaemic stroke

      ea0035p32
    • Circadian cortisol and GH profiles in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy

      ea0035p33
    • High risk for adrenal crises in patients with autoimmune Addison's disease: health insurance data 2008-2012

      ea0035p34
    • Glucocorticoid-induced adrenal insufficiency in prednisolone treated patients and how it relates to glucocorticoid dose and the duration of treatment

      ea0035p35
    • An endocrine dilemma: adrenal tumor

      ea0035p36
    • Cardiovascular outcome in patients with primary aldosteronism following adrenalectomy and mineralocorticoid antagonist treatment: prospective results of the Munich Conn Center

      ea0035p37
    • Mitochondrial thiol systems are important players in antioxidant defence for the human adrenal cortex

      ea0035p38
    • Behavioural research into adrenal insufficiency (AI) patients' perceptions of AI medication, symptoms and adherence: results of a multi-country, European online survey

      ea0035p39
    • 21-hydroxylase autoantibody positivity is influenced by HLA genotype in South African patients with Addison's disease

      ea0035p40
    • Periodic cushing's disease: difficult patient, difficult management

      ea0035p41
    • Could DHEA-S be a novel marker at distinguishing adrenal and pituitary Cushing?

      ea0035p42
    • Detection of high rate of intercurrent illnesses and adrenal crisis in patients with adrenal insufficiency by using a patient's diary

      ea0035p43
    • Bone mineral density does not decrease in patients with adrenal insufficiency on a low daily glucocorticoid dose over a 2 year period

      ea0035p44
    • Markedly elevated glucocorticoids and their metabolites in an unusual case of Cushing's syndrome secondary to ectopic ACTH production from a thymic carcinoid

      ea0035p45
    • Diagnostic performance of late-night salivary cortisol measured by automated chemiluminescenze immunoassay

      ea0035p46
    • Might cortisol modulate food choices in subclinical autonomous glucocorticoids hypersecretion?

      ea0035p47
    • Retrospective analysis of adrenal incidentalomas: a single center experience

      ea0035p48
    • The influence of diagnostic criteria on the interpretation of adrenal venous sampling

      ea0035p49
    • The pathophysiology of aldosterone-producing adenomas associated with their tumor size: the smaller, the higher expression of CYP11B2

      ea0035p50
    • The adrenal venous sampling is a difficult test in the localization of the primary hyperaldosteronism

      ea0035p51
    • Late-night salivary cortisol as an initial test for Cushing's syndrome in the group of patients with obesity and type 2 diabetes mellitus

      ea0035p52
    • Clinical characteristics and follow-up of patients with adrenal incidentalomas

      ea0035p53
    • Effects of non-physiological concentrations of glucocorticoids on apoptotic cell death of human early hematopoietic stem/progenitor cells: in vitro studies

      ea0035p54
    • Effects of adrenal insufficiency on body composition and metabolic indices: data from the European Adrenal Insufficiency Registry (EU-AIR)

      ea0035p55
    • Takotsubo cardiomyopapthy and panhypopituitarism: case report

      ea0035p56
  • Adrenal Medulla
  • • ACTH-producing pheochromocytoma presenting with Cushing's syndrome and complicated by invasive aspergillosis: a case report

      ea0035p57
    • Pheochromocytomas and paragangliomas: association between tumor size and measurements of metanephrines and catecholamines

      ea0035p58
    • The value of metanephrines and normetanephrines influences blood pressure in patients with pheochromocytoma?

      ea0035p59
    • Olygosimptomatic malignant pheochromocytoma treated with 131I-MIBG

      ea0035p60
    • A difficult case of ectopic Cushing's syndrome due to ACTH-producing pheochromocytoma presented with normal fractionated urinary catecholamines and metanephrines

      ea0035p61
    • Expression of IGF/mTOR pathway components in human pheochromocytomas and in vitro inhibition of PC12 rat pheochromocytoma cell growth by mTOR inhibitors alone and in combination with the dual IGFI-R/INS-R antagonist OSI-906

      ea0035p62
    • Asymptomatic catecholamine-producing tumours in Von Hipple-Lindau disease

      ea0035p63
    • Analysis of pheochromocytomas/paragangliomas from Eastern Slovakia

      ea0035p64
  • Bone and Osteoporosis
  • • Postpartum osteoporosis with acute evolution: case report

      ea0035p65
    • The investigation of the awareness of bone health in patients with postmenopauosal in the region of Northeastern Anatolia

      ea0035p66
    • Baseline characteristics of Greek patients enrolled in the ExFOS study

      ea0035p67
    • From EFOS to ExFOS: any news with teriparatide prescription habits in Greece?

      ea0035p68
    • Subclinical celiac disease presented with postpartum low-back pain: case report

      ea0035p69
    • Vitamin D receptor (VDR) gene polymorphisms and the risk of low bone mass in type 1 diabetic patients

      ea0035p70
    • Bone mineral density in Iranian patients: effects of age, sex, and BMI

      ea0035p71
    • Characteristics of the endocrine osteoporosis

      ea0035p72
    • Efficacy of zoledronic acid treatment in Paget disease of bone

      ea0035p73
    • The relationship between the existence and degree of coronary atherosclerosis with the level of parathormone

      ea0035p74
    • What factors influenced on femoral neck bone mineral density in postmenopausal women?

      ea0035p75
    • Serum concentration of pentosidine and adipocytokines is related to fragile bone fractures in patients with type 2 diabetes mellitus

      ea0035p76
    • A girl with a hard painful swelling at the right hip: hyperphosphatemic tumeral calcinosis

      ea0035p77
    • Does testosteron have an effect on bone mineral density in postmenopausal women?

      ea0035p78
    • Renal aspects of primary hyperparathyroidism

      ea0035p79
    • 1,25-dihydroxyvitamin D3 decreases the proinflammatory interleukin 17 serum levels

      ea0035p80
    • Factors associated with vertebral fractures in patients with primary hyperparathyroidism

      ea0035p81
    • Structure of bone disease the different clinical forms of primary hyperparathyroidism

      ea0035p82
    • Low-carbohydrate/high-fat diets do not have negative effects on bone density in female rats in contrast to male rats

      ea0035p83
    • Teriparatide treatment in a patient with severe pregnancy related osteoporosis

      ea0035p84
    • The total fat mass and the fracture risk assessment: a study in 146 Romanian menopausal women

      ea0035p85
    • The 10-year absolute fracture risk and central DXA correlations in 505 Romanian menopausal women

      ea0035p86
    • Bone mineral density, bone turnover and vitamin D status in women with diabetes mellitus type 2 and healthy women with osteoporosis in menopause

      ea0035p87
    • The -857C/T single-nucleotide polymorphism of TNF[alpha] gene is associated with bone mineral density in Greek peri- and postmenopausal women

      ea0035p88
    • State of bone metabolism in patients with urolithiasis

      ea0035p89
    • Familial hypocalciuric hypercalcemia: an important differential diagnosis from hyperparathyroidism

      ea0035p90
    • Usefulness of serum sclerostin as a diagnostic marker of osteoporosis in a cohort of spanish postmenopausal women

      ea0035p91
    • Increased osteoporotic fractures' risk in elderly patients with lower sodium levels

      ea0035p92
    • The effects of recombinant human TSH on selected bone markers in the follow-up of patients treated for differentiated thyroid carcinoma

      ea0035p93
    • Influence of osteoporosis risk factors on extensive suppression of bone metabolism during antiresorptive therapy

      ea0035p94
    • Osteoporosis in young male secondary to cancer treatment: case report

      ea0035p95
    • Jaw osteonecrosis in a patient with postmenopausal osteoporosis on antiresorptive treatment

      ea0035p96
    • Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

      ea0035p97
    • Assessment of OPG and RANKL serum levels after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis

      ea0035p98
    • Effect of estroprogestagen treatment on bone mineral density and concentration of osteoprotegerin in girls with Turner syndrome

      ea0035p99
    • Bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment: a 4-year prospective study

      ea0035p100
  • Calcium and Vitamin D metabolism
  • • Predictive value of early phosphate measurement in post-thyroidectomy hypocalcemia: a prospective study

      ea0035p101
    • The effect of FGF23 on renal phosphorus handling is dependent on PTH secretion

      ea0035p102
    • Screening of genes involved in cAMP-mediated signalling in a large Italian series of patients affected with Albright hereditary osteodystrophy and/or Pseudohypoparathyroidism

      ea0035p103
    • Neurological manifestations of vitamin D deficiency, is there any significant clinical correlation?

      ea0035p104
    • Brown tumor in a patient with ectopic mediastinal parathyroid adenoma: a case report

      ea0035p105
    • Biochemical response and imaging changes in 99mtc-mibi in patiens with primary hyperparathyroidism treated with Cinacalcet

      ea0035p106
    • Reversal heart failure secondary to severe hypocalcaemia

      ea0035p107
    • Novel mutation of the AIRE gene in Iranian patients with autoimmune polyglandular syndrome type 1

      ea0035p108
    • Effect of vitamin D concentration on pregnancy, health of pregnant women, and newborn

      ea0035p109
    • A case of post-operative hypoparathyroidism

      ea0035p110
    • Bone and vitamin D status in young male patients with relapsing kidney lithiasis and hypercalciuria

      ea0035p111
    • Surgery for primary hyperparathyroidism: a 10 years single-centre experience

      ea0035p112
    • Severe hypomagnesemia due to long-term PPI use

      ea0035p113
    • A novel mutation in GATA3 gene in HDR syndrome

      ea0035p114
    • Correlations of vitamin D level with hormonal and biochemical parameters in polycystic ovary syndrome

      ea0035p115
    • Cardiovascular view and QT interval in primary hyperparathyroidism

      ea0035p116
    • New vitamin D less-calcemic analog affects human bone cell line and cultured vascular smooth muscle cells similar to other analogs

      ea0035p117
    • The relationship with plasma calcium levels, metabolic syndrome, and risk parameters in overweight and obese Turkish women

      ea0035p118
    • Levels of vitamin D in patients with various endocrine disorders

      ea0035p119
    • Calcium metabolism in a child with type 1 diabetes mellitus and familial Mediterranean fever

      ea0035p120
    • Retrospective evaluation of patients with primary hyperparathyroidism in Konya Meram Faculty of Medicine

      ea0035p121
    • Frequency of BsmI polymorphism of vitamin D receptor gene and its association with 25-hydroxyvitamin D levels

      ea0035p122
    • Correlation between 25-OH vitamin D3 and TSH concentration in population over 65: preliminary report

      ea0035p123
    • Correlation among arm circumference index, 25-OH vitamin d3 concentration and lipid profile in patients over 65 years: preliminary study

      ea0035p124
    • First seizure presentation in an elderly woman with primary vitamin D deficiency: a case report

      ea0035p125
    • Primary hyperparathyroidism presented with peripheral brown tumor in the oral cavity: a case report

      ea0035p126
    • VDR gene polymorphisms in Alzheimer's disease: pilot study

      ea0035p127
    • Cinacalcet hydrochloride more efficiently controls serum calcium levels in mild-asymptomatic primary hyperparathyroidism without surgery criteria, as compared with surgical cases

      ea0035p128
    • Cardio-metabolic phenotyping of patients with familiar hypocalciuric hypercalcemia

      ea0035p129
    • The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus microvascular complications and vitamin D deficiency

      ea0035p130
    • Evaluation of biochemical cardiovascular risk factors, carotid intima media thickness, and arterial stiffness before and after surgery in patients with primary hyperparathyroidism

      ea0035p131
    • Genu valgum in primary hyperparathyroidism in children

      ea0035p132
    • Interdisciplinary aspects of primary hyperparathyroidism: symptomatology in a series of 100 cases (single-centre experience)

      ea0035p133
    • Serum 25-hydroxyvitamin D deficiency in acute cerebral strokes' patients with and without carbohydrate metabolism disturbances in North-Eastern part of Poland

      ea0035p134
    • Estimation of optimal serum levels of 25-hydroxyvitamin D in a cohort of HIV-infected patients

      ea0035p135
    • Functional parathyroid cyst: a rare cause of hypercalcemia

      ea0035p136
    • Effects of nutritional intervention program on vitamin D serum levels in adolecents

      ea0035p137
    • Acute pancreatitis as the presenting feature and metabolic encephalopathy during the course of newly diagnosed primary hyperparathyroidism

      ea0035p138
    • Ghrelin may have a role in obesity pathogenesis in patients with vitamin D deficiency

      ea0035p139
    • Prospective evaluation of endocrine complications in adults with X-linked hypophosphatemic rickets

      ea0035p140
    • Vitamin D deficiency prevalence before and after sleeve or bypass in morbid obesity

      ea0035p141
    • Vitamin D deficiency in Russian pregnant women and risk for gestational diabetes

      ea0035p142
    • Variety of vitamin D receptor gene polymorphisms and serum levels of vitamin D in patients with type 1 diabetes

      ea0035p143
    • Recurrent post-surgical hyperparathyroidism: think of CYP 24A1 mutations!

      ea0035p144
    • The association between vitamin D deficiency and metabolic parameters in pediatric obesity is influenced by what surrogate index of sunlight exposure is used

      ea0035p145
    • Three patients with idiopathic hypoparatiroidism presented with different clinical manifestations

      ea0035p146
    • Hypoparathyroidism and celiac disease a rare autoimmune disease combination

      ea0035p147
    • Paternal isodisomy is a frequent cause of pseudohypoparathyroidism 1-b

      ea0035p148
    • Frequency of vitamin D deficiency in pregnant diabetics

      ea0035p149
    • Vitamin D seasonal variation of elderly people in Konya Residantal Care

      ea0035p150
    • Oncogenic osteomalasia: a rare case due to lipoma

      ea0035p151
    • The effect of VDR polymorphisms on serum testosterone level in aging men population

      ea0035p152
    • The change in paratyroid hormone level by posture in primary hyperparathyroidism

      ea0035p153
    • Postprandial blood glucose and fetuin-A are independently linked to the coronary calcification progression in patients with type 2 diabetes

      ea0035p154
    • Denosumab increases bone mineral density in primary hyperparathyroidism treated with Cinacalcet

      ea0035p155
    • Vitamin D in men with metabolic syndrome with low or normal testosterone levels

      ea0035p156
    • Is parathyroid hormone venous sampling useful? Correlation of parathyroid hormone selective venous sampling and histopathological results in patients who underwent parathyroidectomy between 2006 and 2013

      ea0035p157
    • Evaluation of the relationship between vitamin D concentration and selected clinical and biochemical features in women with polycystic ovary syndrome

      ea0035p158
    • Hypercalcaemia presenting as hyperemesis gravidarum in a pregnant patient

      ea0035p159
    • PARADIGHM: a natural history registry for patients with chronic hypoparathyroidism

      ea0035p160
    • Cinacalcet in the treatment of primary hyperparathyroidism

      ea0035p161
    • Hypocalcemia caused by type 1b pseudohypoparathyroidism

      ea0035p162
    • Persistant hypercalcemia due to an atypically localised parathyroid adenoma in a patient operated from parathyroid carcinoma: a report of case

      ea0035p163
    • The child with Di George syndrome born to a mother with primary hypothyroidism diagnosed during pregnancy

      ea0035p164
    • Evaluation of vitamin D concentration in a population of young, healthy women: effects of vitamin D supplementation

      ea0035p165
    • Do Lithuanian military conscripts suffer from hypovitaminosis D?

      ea0035p166
    • Unusual case of intrathyroid parathyroid hyperplasia revealed by parathyroid hormone determination in fine-needle aspirate, co-existing with multifocal papillary thyroid carcinoma

      ea0035p167
    • Vitamin D deficiency and tuberculin skin test reaction in old age home residents in Romania

      ea0035p168
  • Cardiovascular Endocrinology & Lipid Metabolism
  • • Cardiothyreosis: pathogenic conjectures, clinical aspects and surgical approach

      ea0035p169
    • Polyphenol-rich dark chocolate lowers LDL oxidation without affecting high-sensitivity CRP levels in adults

      ea0035p170
    • Osteopontin, hs-CRP levels in gestational diabetes mellitus

      ea0035p171
    • Isotretinoin effect on osteopontin, hs-CRP, insulin sensitivity and CIMT in acne patients

      ea0035p172
    • New vitamin D less-calcemic analog affects human bone cell line and cultured vascular smooth muscle cells similar to other analogs

      ea0035p173
    • Oxytocin prevents cardiomyocyte hypertrophy

      ea0035p174
    • Parameters of metabolic syndrome in prehypertensive subjects: should we be looking for them?

      ea0035p175
    • Serum and plasma aldosterone levels and the respective aldosterone/plasma renin indices in healthy blood donors

      ea0035p176
    • Red wine increases SHBG production by HepG2 cells

      ea0035p177
    • New possible predictors of left ventricular hypertrophy

      ea0035p178
    • Characteristics of compensated hypogonadism in patients with sexual dysfunction

      ea0035p179
    • Blood levels of apelin in patients with essential hypertension and type 2 diabetes mellitus and its relationship with the duration of hypertension and anthropometric indices

      ea0035p180
    • Adherence to treatment in hypertension and diabetes

      ea0035p181
    • Evaluation of lipid levels in familial hypercholesterolemia in a lipid unit

      ea0035p182
    • Association between serum thyrotropin levels and insulin resistance in euthyroid patients

      ea0035p183
    • Features of patients with familial hypercholesterolemia treated in a specific lipid unit

      ea0035p184
    • Bariatric surgery effects in lipids levels

      ea0035p185
    • Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals

      ea0035p186
    • Metabolic outcomes in childhood cancer survivors

      ea0035p187
    • The associations between parathyroid hormone level and coronary artery diseases in subjects without significant renal dysfunction

      ea0035p188
    • Serum cholesterol concentration and prevalence, awareness, treatment, and control of high LDL cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010

      ea0035p189
    • Anomalies of the lipid balance in hypothyroidism: comparative study by sex

      ea0035p190
    • The pericarditis in the hypothyroidism

      ea0035p191
    • Vascular calcification: differences between atherosclerotic changes and media sclerosis? A pilot study

      ea0035p192
    • Apelin as a marker of an insulin resistance in patients with essential hypertension

      ea0035p193
    • Insulin dynamics and its associated signalling pathways in equids predisposed to laminitis

      ea0035p194
    • Laminitis: finding the key to predisposition of the metabolic disorder affecting the hoof in equids

      ea0035p195
    • Fetuin-A as a marker of cardiovascular risk in patients with type 2 diabetes

      ea0035p196
    • Osteoprotegerin as a marker of myocardial damage in patients with type 2 diabetes and acute coronary syndrome

      ea0035p197
    • Epigenetic control of renin-angiotensin-aldosterone system in hypertrophic heart

      ea0035p198
    • Occurrence of hipothyreosis in patients with metabolic syndrome

      ea0035p199
    • Flexibility of ectopic lipids in physically active, healthy individuals

      ea0035p200
    • Low testosterone syndrome protects from major adverse cardiovascular events in subjects at high cardiovascular burden

      ea0035p201
    • Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis

      ea0035p202
    • ARR screening using IDS-iSYS aldosterone and direct renin: effects of medication in essential and renovascular hypertension, Cushing's syndrome and primary aldosteronism

      ea0035p203
    • eNOS, p22 phox, CETP and ER[alpha] gene polymorphisms related to metabolic-endocrine parameters in postmenopausal women with metabolic syndrome: a population based study

      ea0035p204
    • Identification of 4 statin benefit groups according to NHLBI ATP IV criteria among Venezuelan women: EEM-lipid study

      ea0035p205
    • Alterations in ambulatory blood pressure monitoring are frequent and associated to cardiovascular risk factors in patients with type 1 diabetes

      ea0035p206
    • Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors

      ea0035p207
    • Total and HDL-cholesterol are lower in lean PCOS women

      ea0035p208
    • LDL cholesterol is higher in overweight and obese PCOS women

      ea0035p209
  • Clinical case reports Pituitary/Adrenal
  • • Diabetes insipidus and hypopituitarism in a patient with idiopathic pulmonary fibrosis

      ea0035p210
    • Can bexarotene be a candidate drug for the medical therapy of Cushing's syndrome?

      ea0035p211
    • Familial 46, XY gonadal dysgenesis

      ea0035p212
    • Comorbidity of gastrointestinal stromal tumor and pituitary macroadenoma in patient referred with gastrointestinal bleeding

      ea0035p213
    • New-onset autoimmune disorders after successful treatment of Cushing's disease

      ea0035p214
    • An unusual clinical presentation of Sheehan's syndrome: Co-occurrence of bycitopenia, acute colonic pseudo-obstruction and acute renal failure

      ea0035p215
    • Challenges in the diagnosis of pheochromocytoma: a case report

      ea0035p216
    • A huge metastatic adrenocortical carcinoma presenting with Cushing's syndrome and inferior vena cava thrombosis: case report

      ea0035p217
    • Synchronous acromegaly and gastrointestinal stromal tumor: a case report

      ea0035p218
    • Cognitive impairment in a patient with a TART syndrome

      ea0035p219
    • Neuropsychiatric aspects in a rare case of hypothalamic obesity

      ea0035p220
    • A case with APECED syndrome

      ea0035p221
    • Hyponatremia as a first symptom of hypopituitarism in an adult patient with natural history of craniopharyngioma undiagnosed since childhood

      ea0035p222
    • Ineffectiveness of temozolomide in aggressive dopamine-agonist resistant prolactinoma and type 3 silent somatotropinoma

      ea0035p223
    • Cushing's disease in patient with primary empty sella

      ea0035p224
    • Temozolomide-induced marked regression of invasive Crooke's cells corticotropinoma in patient with Cushing's disease

      ea0035p225
    • Treatment of aggressive corticotropinoma with temozolomide and bevacizumab in patient with Nelson's syndrome

      ea0035p226
    • Meningitis coexisting with pituitary macroadenoma: report of two cases

      ea0035p227
    • Primary hyperaldosteronism presenting as hypokalemic periodic paralysis: two case reports

      ea0035p228
    • A case of hypopituitarism caused by lung cancer metastasis to the pituitary

      ea0035p229
    • Transient severe polyuria in a patient with bilateral pheochromocytoma after adrenalectomy

      ea0035p230
    • Macroprolactinoma that disappears in a short time with cabergoline treatment: case report

      ea0035p231
    • A case of primary aldosteronism with the subclinical Cushing's syndrome examined the localization by double immunostaining for CYP11B1 and B2

      ea0035p232
    • Primary thyroid lymphoma in a patient with adrenal incidentaloma

      ea0035p233
    • Takotsubo cardiomyopathy triggered by pheocromocytoma crisis

      ea0035p234
    • A history of 30 years severe uncontrolled hypertension: Conn's syndrome

      ea0035p235
    • Unusual cause of hypoglycemia in a type 2 diabetic patient: panhypopituitarism

      ea0035p236
    • Hyperprolactinemia secondary to primary hypothyroidism with hyperplasia pituitary

      ea0035p237
    • A rare cause of primary hyperaldosteronism unilateral adrenal hyperplasia: case report

      ea0035p238
    • Clinical case of pituitary apoplexy due to hemorrhagic vasculitis

      ea0035p239
    • Temporary adrenal failure due to tuberculosis: a rare phenomenon in recent years

      ea0035p240
    • Malignant feminising adrenal tumor without gynecomastia

      ea0035p241
    • Congenital panhipopituitarism and ectopic posterior pituitary

      ea0035p242
    • A case report: functioning cystic pheocromocytoma

      ea0035p243
    • Primary adrenal failure due to primary antiphospholipid syndrome

      ea0035p244
    • Catecholamine resistance hypotension after pheochromocytoma resection

      ea0035p245
    • Prepubertal male gynecomastia-issues of diagnosis

      ea0035p246
    • Spindle cell oncocytoma: a new presentation of a rare disease

      ea0035p247
    • A primary adrenal adenomatoid tumor in a young woman

      ea0035p248
    • Infected giant cystic phaeochromocytoma masquerading as a hepatic abscess

      ea0035p249
    • Hyponatremia and diabetes insipidus: a case report

      ea0035p250
    • Primary hyperthyroidism following successful surgical treatment for secondary hyperthyroidism due to TSH-secreting pituitary adenoma

      ea0035p251
    • A case of addison's disease associated with ankylosing spondylitis

      ea0035p252
    • A case report: posterior pituitary evaluated as microadenoma in the magnetic resonance imaging

      ea0035p253
    • Acromegaly accidentally diagnosed: a typical course of the disease

      ea0035p254
    • Diabetes insipidus as the primary symptom of infundibuloma

      ea0035p255
    • An unusual case of reversible empty sella

      ea0035p256
    • Acromegaly with a normal pituitary gland

      ea0035p257
    • Different courses of Carpenter syndrome

      ea0035p258
    • Hyporeninemic hypoaldosteronism with severe hyperkalemia following adrenalectomy for primary hyperaldosteronism : a case report

      ea0035p260
  • Clinical case reports Thyroid/Others
  • • A new mutation associated with pseudohypoparathyroidism? two case reports

      ea0035p261
    • Prevalence of thyroid abnormalities among psoriatic patients

      ea0035p262
    • Coexisting hurthle cell neoplasm and thyroid hormone resistance

      ea0035p263
    • Primary hyperparathyroidism with severe hypercalcemia during pregnancy

      ea0035p264
    • Acute necrotizing pancreatitis as first manifestation of primary hyperparathyroidism

      ea0035p265
    • Is repeated fine needle aspiration expedient when the first one is nondiagnostic

      ea0035p266
    • Analysis of 40 696 FNAB of thyroid nodules performed in one center

      ea0035p267
    • Functional results of inadvertent parathyroid excision during thyroid surgery

      ea0035p268
    • Scleredema diabeticorum in a nonregulated type 2 diabetic patient

      ea0035p269
    • Rare coexistence of familial mediterranean fever and familial partial lipodystrophy: presented as acute pancreatitis due to severe hypertriglyceridemia

      ea0035p270
    • Localized Aspergillus thyroiditis in patients with diabetic nephropathy

      ea0035p271
    • Drug-induced syndrome of inappropriate antidiuretic hormone secretion

      ea0035p272
    • Heparin-induced hyperkalaemia in a patient with type 2 diabetes: a case report

      ea0035p273
    • A rare variant of papillary carcinoma of thyroid: Warthin-like variant

      ea0035p274
    • Mixed medullary and papillary carcinoma of thyroid

      ea0035p275
    • Morphological and functional imaging allow better characterization of brown tumors in a patient with severe primary hyperparathyroidism

      ea0035p276
    • When mother and daughter become father and son

      ea0035p277
    • Giant mediastinal parathyroid cyst with hyperparathyroidism: a case report

      ea0035p278
    • Three endocrine neoplasms: an unusual combination of pituitary adenoma, papillary thyroid carcinoma, and follicular thyroid carcinoma

      ea0035p279
    • Not a make-up, but an alarm signal of a new onset of Addison's disease

      ea0035p280
    • A carotid body tumor mimicking a thyroid nodule: a case report

      ea0035p281
    • An uncommon infiltrative disease of thyroid: Riedel's thyroiditis

      ea0035p282
    • Primary hyperparathyroidism due to parathyroid carcinoma: case report

      ea0035p283
    • A rare cause of hypocalemia: familial hypoparathyroidism

      ea0035p284
    • The coexistence of anaplastic thyroid carcinoma and papillary thyroid carcinoma: two case reports

      ea0035p285
    • One month-Tadalafil 5 mg once daily administration improves clinical and ultrasound parameters of chronic pelvic pain syndrome/lower urinary tract symptoms

      ea0035p286
    • Recurrent episodes of hypoglycemia caused by insulinoma in a patient with type 2 diabetes mellitus

      ea0035p287
    • Primary hyperparathyroidism due to ectopic mediastinal parathyroid gland at the level of anterior wall of ascending aorta

      ea0035p288
    • Rhabdomyolysis precipitated acute renal injury during levothyroxine withdrawal for remnant ablation in a case with papillary thyroid cancer

      ea0035p289
    • 46,XX/47,XXY mosaic form of klinfelter syndrome with ambiguous genitalia: a case report

      ea0035p290
    • Primary hyperparathyroidism caused by mediastinum located ectopic parathyroid adenoma resected by video-assisted thoracic surgery

      ea0035p291
    • Insulinoma and pregnancy: a case report

      ea0035p292
    • Excessive stimulation of TSH receptor during pregnancy

      ea0035p293
    • Brown tumors: the first and the final manifestation of primary hyperparathyroidism.

      ea0035p294
    • Oncocytic carsinoma with sternum metastasis

      ea0035p295
    • Type 2 polyglandular autoimmune syndrome and Turner syndrome

      ea0035p296
    • Thyroid squamous cell carcinoma

      ea0035p297
    • Patient with alopecia areata

      ea0035p298
    • Breast cancer in multiple endocrine neoplasia type 1

      ea0035p299
    • Congenital TBG production disorder

      ea0035p300
    • Ectopic lingual thyroid gland: two case report

      ea0035p301
    • An unusual case of diabetes mellitus as a result of heterozygous missense mutation R482W in LMNA gene (familial partial lipodystrophy type 2), described for the first time in Russian population

      ea0035p302
    • A patient with lung ectopic parathyroid coexistent with primary hyperparathyroidism and end-stage renal diseases

      ea0035p303
    • Graves-Basedow disease in adolescent patients with type 1 diabetes mellitus

      ea0035p304
    • Follicular thyroid carcinoma presenting with occipital bone and lung metastasis

      ea0035p305
    • Long-term use of tolvaptan in hyponatraemia due to SIADH in elderly

      ea0035p306
    • Challenges in exophthalmia management: Frontal mucocele

      ea0035p307
    • Testicular histological and immunohistochemical particularities in a post-pubertal patient with 5[alpha]-reductase type 2 deficiency

      ea0035p308
    • Treatment of hyponatraemia with vasopressin receptor 2 antagonists (V2RA): case series

      ea0035p309
    • Do clinical events always suggest familial form of medullary thyroid carcinoma (MTC)? - two case reports

      ea0035p310
    • A rare case of cutaneous metastization of a differentiated thyroid carcinoma initially diagnosed as Hurthle cell adenoma

      ea0035p311
    • Diagnosis of neonatal diabetes mellitus in the mother through the detection of hyperglycemia in her child

      ea0035p312
    • Ectopic co-secretion of growth hormone and growth hormone-releasing hormone from a neuroendocrine lung tumor in a patient with MEN1 syndrome

      ea0035p313
    • Refractory Graves' ophthalmopathy treated with rituximab

      ea0035p314
    • Drug induced skin eruption in type 2 diabetes mellitus patients who treating with a dipeptidyl peptidase-4 inhibitor plus metformin

      ea0035p315
    • Severe postmenopausal virilization of unknown origin

      ea0035p316
    • Propylthiouracil induced lupus erythematosus in a patient with Grave's disease: a case report

      ea0035p317
    • Monomorphic ventricular tachycardia due to primary hyperparathyroidism: a case report

      ea0035p318
    • The unusual case of the appearance of radioiodine (I-131) uptake in lung metastases in a patient with papillary thyroid cancer (PTC)

      ea0035p319
    • Recurrent debilitating thyroiditis

      ea0035p320
    • Hashimoto thyroiditis followed by Grave's disease

      ea0035p321
    • Why obesity is multifactorial? Mixture of genetic predisposition, endocrine dysfunction and environmental factors: a case report

      ea0035p322
    • Case study in PTU-induced hepatotoxicity: a retrospective analysis of the key aspects of survivability in PTU-induced hepatotoxicity in adults

      ea0035p323
    • Meningioma in a patient with tall cell papillary thyroid carcinoma

      ea0035p324
    • Hypoglycemia in type 1 diabetes mellitus patient - factual ou factitious?

      ea0035p325
    • From hemoptysis to diagnosis of congenital hypothyroidism: a diagnostic pitfall

      ea0035p326
    • Hirata disease: a rare form of hyperinsulinemic hypoglycemia

      ea0035p327
    • Gynecomastia: a rare etiology

      ea0035p328
    • Two serious complications of propylthiouracil treatment in the same patient: case report

      ea0035p329
    • Brain metastatic disease in a patient with tall cell thyroid carcinoma

      ea0035p330
    • Thyroid papillary microcarcinoma presenting as parotid metastasis: a case report

      ea0035p331
    • Medullary and papillary thyroid cancer metastasis in the same lymph node: case report

      ea0035p332
  • Developmental Endocrinology
  • • Effect of glycemia on sleep indicators for patients with type 1 diabetes mellitus

      ea0035p333
    • Physiological expression of thyroid hormone receptors during zebrafish development and effects of their molecular disruption

      ea0035p334
    • Clinical and molecular profile of patients with gonadal dysgenesis attending tertiary care hospital.

      ea0035p335
    • Crystal structure of Drosophila imaginal morphogenesis protein-Late 2 (IMP-L2) in free form and bound to Drosophila insulin-like peptide 5 (DILP5) and human Insulin-like growth factor-I (hIGF1).

      ea0035p337
    • Genome-wide survey for clinically relevant structural abnormalities contributing to pathogenesis of combined pituitary hormone deficiency (CPHD) with childhood onset.

      ea0035p338
    • Influence of growth hormone therapeutic supplementation on early hematopoietic stem/progenitor cells in patients with growth hormone deficiency (GHD).

      ea0035p339
  • Diabetes (epidemiology, pathophysiology)
  • • Metformin may reduce bladder cancer risk in patients with type 2 diabetes

      ea0035p340
    • Exenatide protects pancreatic islets against brain death-induced inflammation and viability loss

      ea0035p341
    • Higher HDL cholesterol to apolipoprotein A-I ratio is protective against the development of type 2 diabetes

      ea0035p342
    • Relationship between age and Hba1c in Turkish patients

      ea0035p343
    • Features and outcome of stroke related to type 2 diabetes mellitus (T2DM) in a community hospital

      ea0035p344
    • CTRP3 increased the insulin sensitivity of 3T3-L1 adipocyte via decreasing the expression of inflammation factors

      ea0035p345
    • Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus

      ea0035p346
    • Risk of diabetes mellitus after first-attack acute pancreatitis: a national population-based study

      ea0035p347
    • Low rates of attaining LDL goals despite statin use in diabetic patients in a tertiary healthcare center.

      ea0035p348
    • Profile of type 2 diabetic patients according to HbA1c tertiles in our tertiary health care center

      ea0035p349
    • Clinical case of type 1 diabetes mellitus and multiple sclerosis - just bad luck?

      ea0035p350
    • A rare presentation of type 2 diabetes: diabetic ketoacidosis, acute pancreatitis, and hypertriglyceridaemia

      ea0035p351
    • The TLR3 rs3775291 and rs13126816 polymorphisms are associated with risk for developing T1DM

      ea0035p352
    • Association between Asp299Gly and Thr399Ile polymorphisms in TLR4 gene and type 2 diabetes mellitus: Case-control study and meta-analysis

      ea0035p353
    • Age and gender characteristics of carbohydrate metabolism disorders in dependance on HbA1c level

      ea0035p354
    • Prevalence of bronchial asthma in patients with type 2 diabetes mellitus

      ea0035p355
    • Prevention of cardiovascular lesions by active detection of diabetes mellitus

      ea0035p356
    • Screening on type 2 diabetes mellitus incidence in Tashkent

      ea0035p357
    • Epidemiology of type 1 diabetes mellitus in children in Uzbekistan

      ea0035p358
    • The rs1746661 polymorphism in the FNDC5 (Irisin) gene is associated with increased levels of total cholesterol in white patients with type 2 diabetes mellitus

      ea0035p359
    • Atherosclerosis in patients with prediabetes and type 2 diabetes is associated with more significant microcirculation abnormalities

      ea0035p360
    • Relationship between indices of nutriture among residents of a Coastal City in South East Nigeria

      ea0035p361
    • Pregnancy outcomes in women with gestational diabetes

      ea0035p362
    • Intensive and expensive new treatments or better education for patients with diabetes: Where should we begin with?

      ea0035p363
    • Does systematic error in the HbA1c measurement matter when locally analyzed HbA1c is used for benchmarking in a national diabetes register?

      ea0035p364
    • UCP1, UCP2 and MnSOD expression in pancreas from brain-death subjects: A case-control study

      ea0035p365
    • Association between UCP polymorphisms and BMI changes: A cross-sectional study and meta-analysis

      ea0035p366
    • Serum cytokines and proinflammatory markers in first degree relatives of patients with type 1 diabetes

      ea0035p367
    • Increased prevalence of anti-thyroid and anti-gastric parietal cell antibodies in first degree relatives of patients with type 1 diabetes

      ea0035p368
    • Sexual function of 26-36-year-old men with type 1 diabetes

      ea0035p369
    • Compensatory increased irisin levels in gestational diabetes mellitus

      ea0035p370
    • GCK-MODY caused by a new mutation in the GCK gene

      ea0035p371
    • Branched-chain and aromatic amino acid plasma concentration as a markers of metabolic syndrome

      ea0035p372
    • Acromegaly treatment and carbohydrate metabolism disturbances

      ea0035p373
    • New onset T1DM after vaccination for measles: Coincidence or consequence?

      ea0035p374
    • Adipokines, insulin resistance in early pregnancy and risk for gestational diabetes

      ea0035p375
    • Prevalence of androgenic deficit in men with metabolic alterations

      ea0035p376
    • Assessment of relaxin levels in pregnant women with gestational diabetes mellitus

      ea0035p377
    • Low serum 25(0H) vitamin D3 concentration is associated with increased accumulation of advanced glycation endproducts (AGEs) in the skin of patients with type 1 diabetes

      ea0035p378
    • Mean platelet volume reflects framingham risk score in intermediate hyperglycemia

      ea0035p379
    • Anthropometric and biochemical parameters in older women with a history of gestational diabetes

      ea0035p380
    • Changes of sphingolipid profiles in serum of patients with diabetes

      ea0035p381
    • Iranians face with the same barriers to diabetes self management as people in other parts of the world. Need for family support

      ea0035p382
    • Low apelin levels are associated with a marked increase in risk for development of the gestational diabetes mellitus

      ea0035p383
    • Translating the A1C assay into estimated average fasting glucose values: Data from the 2011 Korea National Health and Nutrition Examination Survey V

      ea0035p384
    • Presence of erythrocytosis in a patient with concomitant type 1 diabetes mellitus and Gitelman syndrome

      ea0035p385
    • Incidence of type 1 diabetes mellitus over 21 consecutive years among 15-39-year aged Lithuanian population

      ea0035p386
    • The HLA-A*33 haplotype enhances the risk of type 1 diabetesin ndividuals with HLA-DR3+ or DR9+ haplotype

      ea0035p387
    • What is the contribution of MODY gene polymorphisms in the development of gestational diabetes mellitus?

      ea0035p388
    • Characterization of severe hypoglycemia episodes evaluated in the emergency department of a central hospital

      ea0035p389
    • Characterization of the episodes of severe hypoglycemia evaluated by a pre-hospital care unit of a reference hospital

      ea0035p390
    • Vitamin D, insulin dependency and BMI in type 1 diabetes

      ea0035p391
    • Resistin mRNA expression in fat and placental tissue of patients with gestational diabetes

      ea0035p392
    • Clinic blood pressure shows low sensitivity to detect alterations in ambulatory blood pressure monitoring in patients with type 1 diabetes

      ea0035p393
    • Increased prevalence of hepatocellular carcinoma in patients with cirrhosis and insulin resistance candidate to liver transplantation

      ea0035p394
    • Alterations in ambulatory blood pressure monitoring are associated to proinflammatory cytokines in patients with type 1 diabetes

      ea0035p395
    • Vitamin D and diabetes mellitus type 2

      ea0035p396
    • Features of patients with LADA in a Diabetes Unit

      ea0035p397
    • Paper of oxidative stress and placenta on the development of gestational diabetes mellitus

      ea0035p398
    • Evaluation of the approach to diabetic patients before the first admission to diabetologist: Is there a room for the improvement?

      ea0035p399
    • Impact of Impaired Fasting Glucose on Blood Pressure and Vascular Risk Profile of Normotensives and Untreated Hypertensive Subjects

      ea0035p400
    • In human retina the A allele of the [mdash]866G/A polymorphism in the UCP2 gene is associated with increased UCP2 protein concentrations

      ea0035p401
    • Association of the UCP polymorphisms with susceptibility to obesity: case-control study and meta-analysis

      ea0035p402
  • Diabetes complications
  • • Does proton pump inhibitor use decrease microvascular complicaton rate in type 2 diabetic patients? A retrospective analysis

      ea0035p403
    • The relation of left ventricular hypertrophy and markers of inflammation in type 2 diabetic patients

      ea0035p404
    • Incidence and cost of complications among men and women with type 2 diabetes

      ea0035p405
    • Is the ankle-brachial index directly associated with current glycemic control in diabetic patients? Preliminary results of our study

      ea0035p406
    • Abstract unavailable

      ea0035p407
    • Angiogenic factors and circulating endothelial progenitor cells in patients with type 2 diabetes mellitus

      ea0035p408
    • Associated study of polymorphic variants in the gene for superoxide dysmutase (Mn SOD) and different types of diabetes mellitus

      ea0035p409
    • Depression risk factors in type 1 diabetes mellitus

      ea0035p410
    • Disabilities of the arm, shoulder and hand questionnaire and diabetic complications: preliminary results

      ea0035p411
    • Relation between psychiatric symptoms and diabetic complications: preliminary results

      ea0035p412
    • The diabetic hand: a forgotten complication?

      ea0035p413
    • The results of evaluation of dynamics of levels of glycemia in diabetes mellitus type 1

      ea0035p414
    • Analysis of diabetic retinopathy risk factors in type 2 diabetes patients

      ea0035p415
    • Treatment of ulcer-necrotic manifestations of diabetic foot using ultrasonic cavitation

      ea0035p416
    • Genetic dependence of urinary enzyme, neutral [alpha]-glucosidase, in diabetic nephropathy in uzbek children and adolescents with type 1 diabetes mellitus

      ea0035p417
    • Activity of neutral [alpha]-glucosidase in the urine of children and adolescents with type 1 diabetes mellitus and diabetic nephropathy

      ea0035p418
    • Prevalence and risk factors of prolonged QTc interval in type 2 diabetic patients; impact of the type of treatment and quality of glycemic control

      ea0035p419
    • Patients with type 1 diabetes and thyroid autoimmunity have low prevalence of microangiopathic complications

      ea0035p420
    • Relationship between diabetes mellitus and hemostasis: a prothrombotic condition

      ea0035p421
    • Androgendeficiency in men with type 2 diabetes mellitus

      ea0035p422
    • Characteristic features of the course of chronic venous insufficiency of the lower limbs in patients with impaired peripheral innervation of diabetes mellitus type 2

      ea0035p423
    • Abstract unavailable

      ea0035p424
    • Benfotiamine efficiency in the stabilization of diabetic peripheral polyneuropathy

      ea0035p425
    • Association of angiotensin-converting enzyme gene I/D polymorphism and aldosterone synthase (CYP11B2) gene [mdash]344T/C polymorphism with the risk of nephropathy in diabetic patients

      ea0035p426
    • Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism markers and bone mineral density

      ea0035p427
    • Higher levels of osteoprotegerin and S-RANKL in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast activity and predisposition to lower bone mass

      ea0035p428
    • The association of peripheral artery disease with renal function and albuminuria in diabetic patients

      ea0035p429
    • Low FT4 syndrome in gestational diabetes

      ea0035p430
    • Metabolic syndrome and cardiovascular risk are less prevalent in LADA vs type 2 diabetes patients

      ea0035p431
    • Erectile dysfunction scores are lower in type 2 diabetes mellitus but not correlate with carotis intima media ticknes or coronary arter disease

      ea0035p432
    • Diabetic polyneuropathy as the only diabetes related complication associated with higher likelihood and more severe forms of erectile dysfunction in type 2 diabetes

      ea0035p433
    • The influence of maternal BMI and weight gain in gestational diabetes: results of the Portuguese population in 2011

      ea0035p434
    • Hemostatic biomarkers in selected group of patients with type 1 diabetes: are they associated with different degrees of diabetic retinopathy

      ea0035p435
    • Markers of endothelial dysfunction in type 1 diabetics with or without microalbuminuria

      ea0035p436
    • Skin findings among diabetic patients

      ea0035p437
    • Vascular endothelial growth factor polymorphism +405 G/C is associated with early stage of diabetic nephropathy in patients with type 2 diabetes

      ea0035p438
    • Analysis of ultrasound structure of the thyroid gland and assessment of structural changes in patients with diabetes mellitus type 1 at different stages of chronic kidney disease

      ea0035p439
    • Comparative analysis of methods for the evaluation of renal function in patients with diabetes mellitus type 1 at different stages of chronic kidney disease

      ea0035p440
    • QT intervals and vitamin D levels in diabetic patients

      ea0035p441
    • Dental care and periodontal disease in Turkish diabetic patients

      ea0035p442
    • Clinical profile and management of diabetic osteoarthropathy

      ea0035p443
    • Comparative assessment of parathyroid hormone and bone turnover markers in diabetic and non-diabetic patients with end-stage chronic kidney disease

      ea0035p444
    • Autoimmune pancreatitis after intravenous insulin desensitization in a diabetic patient allergic to insulin without pancreatic reserve

      ea0035p445
    • A lepromatous lepra case presented like diabetic foot

      ea0035p446
    • Prolonged cerebellar ataxia after: severe hypoglycemic attack in a patient with T1DM: a rare but disturbing sequela

      ea0035p447
    • Mean platelet volume in type 2 diabetic patient: is there a relationship between mean platelet volume and diabetic microvasculary complications?

      ea0035p448
    • Small fibre neuropathy association with increased mortality in patients with chronic kidney disease, with or without diabetes mellitus

      ea0035p449
    • Diabetic neuropathy in a young patient with recently diagnosed diabetes mellitus: an atypical presentation of insulin neuritis

      ea0035p450
    • Abstract unavailable

      ea0035p451
    • Associations of serum lipid levels with diabetic retinopathy in type 1 diabetics

      ea0035p452
    • Effect of diabetic nephropaty on lipid profiles of adult type 1 diabetics

      ea0035p453
    • Vasoinhibins are natural inhibitors of angiogenesis in the vitreous and are impaired in patients with diabetic retinopathy

      ea0035p454
    • The correlation of foetal ultrasound and HbA1c with birth weight in women with gestational diabetes

      ea0035p455
    • Undiagnosed diabetes mellitus presenting as thrombosis of the portal venous system: case report

      ea0035p456
    • Diabetic ketoacidosis and olanzapine: case report

      ea0035p457
    • Intima: media thickness and endothelial dysfunction in GCK and HNF1A MODY patients

      ea0035p458
    • Prevalence of gastrointestinal diseases in the newly diagnosed pre-diabetic and diabetic patients

      ea0035p459
    • The influence of type 2 diabetes mellitus on periodontal disease

      ea0035p460
    • Diabetes and end-stage renal disease: clinical evaluation of diabetic renal transplant candidates

      ea0035p461
  • Diabetes therapy
  • • The role of the community pharmacist in managing patients with diabetes type 2

      ea0035p462
    • Trends of oral anti-diabetic drug usage amongst general practitioners of North-East India: an audit

      ea0035p463
    • The outcome of [beta] cell function after early insulin therapy in the recently diagosed type 2 diabetes (in Egyptian population) our experience in EL-Minia university hospital

      ea0035p464
    • Metabolic control of our turkish diabetic patients on exenatide therapy: good at metabolic control but how about compliance?

      ea0035p465
    • Effect of 7 weeks endurance exercise on insulin resistance and RBP4 protein expression in liver and adipose tissue in type 2 diabetic rats

      ea0035p466
    • Diabetic ketoacidosis simulator: a new learning tool for a life threatening condition

      ea0035p467
    • Does statin use impairs glycaemic control in type 2 diabetic patients? A retrospective analysis

      ea0035p468
    • Effect of angiotensin receptor blockers on glycaemic control in type 2 diabetic patients? A retrospective analysis

      ea0035p469
    • Comparison of angiotensin receptor blockers and angiotensin converting enzyme inhibitors for glycaemic regulation

      ea0035p470
    • Potential role of state of zinc metabolism in biguanides efficiency in hypoglycemic therapy

      ea0035p471
    • Repetetive training of diabetic patient for medical nutrition and insulin therapy can improve the metabolic control

      ea0035p472
    • Study on pregnancy outcomes in patients with type I diabetes mellitus having self-control skills

      ea0035p473
    • Is psychological support the missing ingredient in successful outcomes for pancreas transplantation: the importance of recognising and managing the 'competitive patient'

      ea0035p474
    • Improvement of HbA1c is blunted following discontinuation of an on-line telemonitoring system, in patients with inefficiently controlled insulin-treated diabetes mellitus

      ea0035p475
    • Could favorable effects of liraglutide on steato-hepatitis be independent of weight loss in type 2 diabetes? A case report

      ea0035p476
    • Embryonal antitumor modulator's preventive action on streptozotocin induced damage of mouse pancreatic [beta] cells in primary culture

      ea0035p477
    • Hypogonadal men with cardiovascular diseases benefit from long-term treatment with testosterone undecanoate: observational data from a registry study

      ea0035p478
    • Gastric contractility modulation: a novel method for the treatment of type 2 diabetes mellitus with overweight and obesity: a preliminary results of the clinical study

      ea0035p479
    • The role of continuous subcutaneous insulin infusion therapy in a case of Seip-Berardinelli congenital lipodystrophy

      ea0035p480
    • Type 2 diabetic patients can benefit by switching from premixed insulin analogues to detemir and aspart insulin

      ea0035p481
    • Prospective study of healthy lifestyle on diabetes mellitus

      ea0035p482
    • Self-monitoring of blood glucose and perceived obstacles in Turkish patients with diabetes mellitus

      ea0035p483
    • Normal and extended release form of metformin in type 2 diabetic and pre-diabetic patients.

      ea0035p484
    • Teaching system of self-control in endocrinology

      ea0035p485
    • Treatment with dipeptidyl peptidase-4 inhibitors may induce bullous pemphigoid in patients with type 2 diabetes

      ea0035p486
    • Changes in insulin sensitivity and DHEAS in type 2 diabetic men treated with liraglutide

      ea0035p487
    • Basal bolus insulin therapy in hospitalised patients with diabetes mellitus type 2 using two algorithms embedded in a tablet PC

      ea0035p488
    • Influence of different modes insulin on carbohydrate metabolism, state transplant, control of metabolic and hemodynamic factors in patients with type 1 diabetes during the 1st year after kidney transplantation

      ea0035p489
    • The effects of metformin therapy on bone resorption and bone formation markers in newly diagnosed patients with type 2 diabetes mellitus

      ea0035p490
    • The favourable effects of autologous hematopoietic stem cell transplantation on the immune system in patients with type 1 diabetes

      ea0035p491
    • The effect of continuous subcutaneous insulin infusion therapy on acute complications and pregnancy outcome in pregnant women with type 1 diabetes mellitus

      ea0035p492
    • Effect of omega-3 polyunsaturated fatty acids on insulin resistance in type 2 diabetes

      ea0035p493
    • Inhibition of SGLT using Ca2+-zeolite and preserve the periphery of glucose excess

      ea0035p494
    • Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database

      ea0035p495
    • Evolution of ambulatory blood pressure monitoring in a cohort of patients with type 1 diabetes after 7 years

      ea0035p496
    • The evaluation of the long-term effect of insulin pump therapy in children with type 1 diabetes mellitus

      ea0035p497
    • Insulin infusers: 8 years experience

      ea0035p498
    • Differential effects of native Peptide YY and its long acting analogue (Y-59) on innate lymphocyte function and anti-tumour activity

      ea0035p499
    • Liraglutide effects on glycaemic control, body weight, blood pressure and lipid profile in obese patients with type 2 diabetes: real-life clinical practice

      ea0035p500
    • Is there a relationship between body composition and insulin regimen modality in type 1 diabetic patients?

      ea0035p501
  • Endocrine disruptors
  • • Acute exposure of BPA from electronic gadgets does not induce oxidative stress in the rat's brain

      ea0035p502
    • The reproductive toxicity of butyl benzyl phthalate in male rabbits: the possible protective role of flaxseed

      ea0035p503
    • Treatment with kaempferol resulted in the regulation of cell cycle-related and apoptosis-related genes in cancer cell growth caused by triclosan in MCF-7 breast cancer cells

      ea0035p504
    • Treatment of prostate cancer cells with phthalate resulted in the upregulation of cyclin D1 and c-myc and downregulation of p21 via estrogen receptor signaling pathway in the progression of LNCaP prostate cancer cells

      ea0035p505
    • Treatment of breast cancer cells with triclosan and octylphenol altered the expressions of cyclin D1 and p21 and induced breast tumor masses via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models

      ea0035p506
    • Transcriptional levels of aryl-hydrocarbon receptor, aryl-hydrocarbon receptor dependent- and cell cycle-related genes were altered by fenhexamid in human ovarian cancer cells expressing estrogen receptors

      ea0035p507
    • Transcriptions of cell cycle-related genes were altered by benzylbutyl phthalate and diisobutyl phthalate via an estrogen receptor [alpha] signaling pathway in human ovarian cancer cells

      ea0035p508
    • Estrogen and bisphenol A affect enamel formation by different signaling pathways

      ea0035p509
    • Organometric parameters of rat's adrenal glands after 60-day administration of sodium benzoate and application of mexidol

      ea0035p510
    • The potential role of bisphenol A in the pathogenesis of polycystic ovary syndrome

      ea0035p511
    • Bisphenol A disrupts seminoma cell proliferation following an inverted U-shaped non monotonic dose-response curve, due to its greater affinity for GPR30, the non classical membrane G protein-related estrogen receptor, than for ER[beta]

      ea0035p512
    • Di-ethylhexyl-phthalate is metabolised by human thyroid cells and may influence thyroglobulin secretion

      ea0035p513
  • Endocrine tumours and neoplasia
  • • Novel and classical molecular pathways identified in pituitary tumorigenesis using mRNA profiling

      ea0035p514
    • Our experience in the evaluation criteria used for the genetic study of patients suspected of being affected by multiple endocrine neoplasia type 1 and mutational spectrum

      ea0035p515
    • The truncated somatostatin receptor sst5TMD4 stimulates the production of pro-angiogenic factors in in vitro and in vivo breast cancer models

      ea0035p516
    • The effects of cAMP in different neuroendocrine tumorous cells: the role of Epac and PKA in cell proliferation and cell adhesion

      ea0035p517
    • Molecular mechanisms of unexpected promoting effects of progesterone and mifepristone on granulosa cell tumorigenesis

      ea0035p518
    • BRAF V600E mutation in washing liquid of thyroid fine-needle aspiration: a surprising tool in cytological benign nodules

      ea0035p519
    • Classic ductal sonographic criteria vs real-time elastography criteria in diagnosing nodular breast lesions

      ea0035p520
    • A case of insulinoma localized in pancreas tail that cannot be monitored with endosonography and abdominal MR but with contrast abdominal BT

      ea0035p521
    • Adrenocortical carcinoma: a review of four cases

      ea0035p522
    • A rare case of an androgen-producing stromal luteoma of the ovary in a postmenopausal woman, diagnosed by means of selective venous blood sampling

      ea0035p523
    • Fnab and calcitonin wash-out during exenatide therapy

      ea0035p524
    • The presence of B-RAF V600E and K601E mutations in our Ligurian population

      ea0035p525
    • The use of demeclocyclin in the syndrome of paraneoplastic inappropriated secretion of anti-diuretic hormone: about one observation

      ea0035p526
    • Could non-functional adrenal incidentaloma be a risk factor for atherosclerosis and metabolic disturbances?

      ea0035p527
    • Retrospective evaluation of adrenal incidentalomas in a tertiary care institution

      ea0035p528
    • A rare ovarian carcinoma

      ea0035p529
    • Clinical management of insulinomas: a single institution's experience

      ea0035p531
    • Comparison of chromogranin A levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males

      ea0035p532
    • High JAG1 expression in adrenocortical carcinomas is associated with better prognosis

      ea0035p533
    • Role of metformin on recurrence-free survival in neuroendocrine tumors

      ea0035p534
    • Expression of inhibitor of apoptosis protein BIRC7/livin in adrenocortical tumors

      ea0035p535
    • Aurora kinases inhibitors Vx-680, SNS314 and ZM447439 in adrenocortical tumors

      ea0035p536
    • Sunitinib induced hypocalcaemia during treatment of pancreatic neuroendocrine tumours

      ea0035p537
    • Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids

      ea0035p538
    • Follicular lesion of undetermined significance in thyroid nodules fine needle aspiration cytology: a revision of 95 cases

      ea0035p539
    • Monitoring of pheochromocytomas development in proto-oncogene RET mutation's carriers

      ea0035p540
    • Efficiency of ultrasound-guided percutaneous thyroid nodule biopsy among patients hospitalized in the department of internal medicine

      ea0035p541
    • Multiple endocrine neoplasia type 1 and 2: a retrospective study

      ea0035p542
    • The prevalence of malignancy in thyroid incidentalomas in an iodine-replete area

      ea0035p543
    • A major Endocrine Unit's experience: the combined role of ultrasound scans and fine needle aspiration in the management of thyroid nodules

      ea0035p544
    • Ultrasonography as a first-line investigation of thyroid nodule: is it still the case? An audit to examine and reflect on our practice in a regional endocrine unit

      ea0035p545
    • Pheochromocytoma and neurofibromatosis type 1: description of case

      ea0035p546
    • Ganglioneuroma of the adrenal gland: a case report

      ea0035p547
    • Efficacy and safety of transarterial chemoembolization of unresectable neuroendocrine liver metastases

      ea0035p548
    • Efficacy of lanreotide autogel in men1-related gastrinomas: a case series

      ea0035p549
    • The effectiveness of yttrium90/lutetium177-labeled somatostatin analogues treatment in functional pNETs

      ea0035p550
    • Evaluation of vegf and endocan/esm-1 expression in pnets and correlation with Ki67 and prognosis

      ea0035p551
    • Insulinoma, recurrent hypoglycaemia: a debilitating condition

      ea0035p552
    • Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) - 10 year experience of one center

      ea0035p553
    • Epidemiology of gastro-entero-pancreatic neuroendocrine tumors in Krakow and Krakow district area

      ea0035p554
    • Factors influencing survival of patients diagnosed with gastro-entero-pancreatic neuroendocrine tumors in Krakow and Krakow district area

      ea0035p555
    • Catecholamin crisis as a first manifestation of multiple endocrine neoplasia type 2A

      ea0035p556
    • Adrenal incidentaloma: is it a disease of elderly? A clinical study of 2650 cases registered at a single endocrinological center

      ea0035p557
    • Abstract unavailable

      ea0035p558
    • Evaluation of demographic data of patients with adrenal incidentalomas

      ea0035p559
    • Expression of FSH hormone receptors in pituitary adenomas: a marker of tumour aggressiveness?

      ea0035p560
    • Malignacy prevalance and related conditions in adrenal incidetaloma

      ea0035p561
    • Consolidation treatment with somatoatatin analogues after radiopeptide therapy

      ea0035p562
    • Analysis of ultrasonographic parameters influencing thyroid nodules elasticity

      ea0035p563
    • Differential TNF[alpha] and Toll-like-receptor 4-signaling in endocrine tumors after tumor- vascular- disrupting Agent ASA404 (Vadimezan) and TNF[alpha] treatment

      ea0035p564
    • Effect of thiazolidinediones: PPAR[gamma] agonists on hormones secretion by cells of human adrenocortical cancer in vitro

      ea0035p565
    • Primary neuroendocrine carcinoma of renal: a rare case report

      ea0035p566
    • Neuroendocrine carcinomas of the thymus: two case reports

      ea0035p567
    • Expression of prolactin receptor in aldosterone-producing adrenal adenomas

      ea0035p568
    • Patient with dissemination of neuroendocrine neoplasm of unknown origin and carcinoid syndrome: diagnostic and therapeutic difficulties

      ea0035p569
    • Uncertain clinical prognosis of pancreatic neuroendocrine tumour: case report

      ea0035p570
    • Androgens regulate gene expression of glucose transporters and glycolytic enzymes in prostate cancer cells

      ea0035p571
    • Peptide receptor radionuclide therapy as neoadjuvant treatment

      ea0035p572
    • CD56 immunohistochemical expression: a useful tool for the diagnosis of in thyroid carcinomas of follicular origin

      ea0035p573
    • A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity

      ea0035p574
    • Chemoembolization as a locoregional treatment for metastatic disease on a liver transplant from a bronchial carcinoid neuroendocrine tumor

      ea0035p575
    • Correlation between atypical pituitary adenomas and Ki-67 Li: clinical and prognostic aspects

      ea0035p576
    • Patient-reported outcomes associated with lanreotide Autogel (LAN-ATG) for symptom control of carcinoid syndrome in gastroenteropancreatic neuroendocrine tumour patients: results of SYMNET, a large International Multicentre Observational Study

      ea0035p577
    • Antiproliferative effects of lanreotide Autogel in patients with enteropancreatic neuroendocrine tumours: results of CLARINET, a large international phase 3 study

      ea0035p578
    • Efficacy and safety of lanreotide Autogel treatment for carcinoid syndrome in patients with gastroenteropancreatic neuroendocrine tumors: results of ELECT, a large multinational phase 3 study

      ea0035p579
    • Plasma free metanephrine, normetanephrine and 3-methoxytyramine for the differential diagnosis of pheochromocytoma and paraganglioma

      ea0035p580
    • Is early repeat surgery a feasible concept for potential incomplete resection in acromegaly?

      ea0035p581
    • Eleven base pair (AACACTCTAGC) deletion of SDHB Ex-4 from c.325 to c.335 in the patient with malignant Vaginal Paraganglioma - A case report

      ea0035p582
    • 99mTc-GLP-1 scintigraphy, an efficient method for the detection of insulinoma: results of 3 years' experience

      ea0035p583
    • The first experience of video-assisted resection of the thyroid gland in the Republic of Kazakhstan

      ea0035p584
    • Combined therapy PRRT with long acting somatostatin analogue: results of 7 years' experience

      ea0035p585
    • The anti-proliferative effect of anti-EGFR tyrosine kinase inhibitor in combination with mitotane on H295R adrenocortical cancer cells

      ea0035p586
    • Gonadal tumor incidence in 45,X/46,XY and 46,XY female patients: experience from one clinical center

      ea0035p587
    • Ovarian tumors in endocrinology: about a series of 17 cases

      ea0035p588
    • Asymptomatic advanced neuroendocrine ovarian tumor: case report

      ea0035p589
    • Analysis of factors affecting the repeatability and reproducibility of elastographic measurements of thyroid nodules

      ea0035p590
    • Should unifocal papillary thyroid microcarcinoma be treated as much radically as multifocal one?

      ea0035p591
    • Pancreatic neuroendocrine tumour with a silent long evolution: case report

      ea0035p592
    • IGF1 gene polymorphism and thyroid cancer

      ea0035p593
    • Comparison of elastography and conventional ultrasonography in the diagnostics of thyroid nodules, elastographic features of follicular lesions of undetermined significance

      ea0035p594
    • Preoperative octreotide therapy in acromegaly: associations between effects on glucose homeostasis and biochemical cure

      ea0035p595
    • Pulmonary neuroendocrine tumor presenting with thyroid gland metastasis: a case report

      ea0035p596
    • Everolimus in monotherapy as a therapeutic option in paragangliomas/pheochromocytomas

      ea0035p597
    • Expression of somatostatin and dopamine receptors in neuroendocrine tumors: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores

      ea0035p598
    • Analysis of allelic imbalance frequency in 10q region covering PAPSS2 and PTEN loci in follicular cell-derived thyroid tumours

      ea0035p599
    • Cushing's syndrome caused by ectopic corticotrophin secretion

      ea0035p600
    • Expression of proliferating markers: PCNA and Cdk1 in hyperplastic lesions of the parathyroid glands

      ea0035p601
    • Immunohistochemical assessment of parafibromin in primary hyperparathyroidism

      ea0035p602
    • Apoptotic cell index in non-neoplastic lesions of the parathyroid glands

      ea0035p603
    • Neuroendocrine cancer of the ampulla of Vater: clinical course in seven patients: material of Department of Endocrinology in Szczecin, Poland

      ea0035p604
    • 'Noninsulinoma pancreatogenous hypoglycemia syndrome'; a case report of adult nesidioblastosis from Turkey

      ea0035p605
    • Breast metastasis from medullary thyroid carcinoma in a man

      ea0035p606
    • A rapid thymic carcinoma in a patient with multiple endocrine neoplasia type 1

      ea0035p607
    • Metastatic bone disease in patients with neuroendocrine tumors

      ea0035p608
    • Adrenocortical carcinomas: retrospective analysis of the last 22 years

      ea0035p609
    • The value of parathyroid hormone determination in ultrasound-guided fine-needle aspirates (FNA-PTH) for preoperative localization of parathyroid lesions.

      ea0035p610
    • TSH suppressive therapy accelerates progression of sacropenia in post-menopausal women

      ea0035p611
    • Metabolic and cardiovascular complications in patients with adrenal incidentalomas

      ea0035p612
    • Circulating tumor cells in neuroendocrine tumor patients

      ea0035p613
  • Female reproduction
  • • Tissue glucose utilization in the different phenotypes of PCOS women

      ea0035p614
    • Post load glucose and insulin vs fasting levels in prediction of type 2 diabetes in women with PCOS

      ea0035p615
    • Screening for cushing syndrome in women with hirsutism and oligomenorrhea

      ea0035p616
    • Identification of elevated urine kisspeptin in pregnant women: a novel non-invasive biomarker of placental function?

      ea0035p617
    • Changes in body composition following 12 months randomized treatment with metformin vs oral contraceptives vs combined treatment in polycystic ovary syndrome

      ea0035p618
    • Serum cocaine and amphetamine-regulated transcript concentrations in women with polycystic ovary syndrome

      ea0035p619
    • Plasma levels of nesfatin-1 in patients with polycystic ovary syndrome

      ea0035p620
    • Pregnancy in women with polycystic ovary syndrome is associated with higher risk of gestational diabetes mellitus, but not of other adverse obstetric outcomes

      ea0035p621
    • Study on pregnancy outcomes in patients with type 1 diabetes mellitus having self-control skills

      ea0035p622
    • Liver enzymes in normal-weight women with polycystic ovary syndrome

      ea0035p623
    • Prevalence of metabolic syndrome in obese women with polycystic ovary syndrome

      ea0035p624
    • Prevalence of dysglycaemia in obese women with polycystic ovary syndrome

      ea0035p625
    • Simultaneous determination of salivary androgens by liquid chromatography-tandem mass spectrometry: analytical and biological validation

      ea0035p626
    • Mosaic Turner syndrome and pituitary microadenoma in patient with polyglandular autoimmune syndrome type II

      ea0035p627
    • New endocrine and intracellular regulators of reproductive functions

      ea0035p628
    • Birth weight is associated with important clinical and biochemical parameters of PCOS

      ea0035p629
    • Expression of P450arom mRNA in the ovary and brain of Indian teleosts, Labeo rohita and Anabas testudineus: seasonal variation and effects of gonadotropin

      ea0035p630
    • The relationship between clinico-biochemical features in women with polycystic ovary syndrome and fertility treatment outcomes

      ea0035p631
    • Primary amenorrhea due to gonadal disgenesis: chromosome 13 abnormality not detected previously: a case report

      ea0035p632
    • Increased occurrence of proinflammatory IL17, IL6 and MCP-1 cytokines and resistin with the overweight-associated polycystic ovarian syndrome, pituitary adenome and obesity

      ea0035p633
    • Mice lacking anti-Mullerian hormone signaling are protected against the age-related decline in metabolism

      ea0035p634
    • Thyroid disorders in young females with polycystic ovary syndrome: is thyroid volume associated with serum IGF1 level?

      ea0035p635
    • The prevalence of autoimmune thyroiditis and hypothyroidism in PCOS women

      ea0035p636
    • Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women

      ea0035p637
    • Wolfram syndrome with hypergonadotropic hypogonadism: case report

      ea0035p638
    • rhAMH inhibits CYP19 and P450scc mRNA expression in granulosa-lutein cells treated with gonadotropin

      ea0035p639
    • The obesity effects on features of polycystic ovary syndrome

      ea0035p640
    • Relationship between visceral adiposity index, menstrual disorders and hormonal, biochemical and ultrasound parameters in women with polycystic ovary syndrome

      ea0035p641
    • Elevated environmental testosterone equivalent concentration in women with polycystic ovary syndrome

      ea0035p642
    • The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro

      ea0035p643
    • The PCOS evolutionary paradox: a GWAS-based, in silico, evolutionary explanation

      ea0035p644
    • How to estimate insulin resistance in PCOS patients: HOMA-IR or QUICKI?

      ea0035p645
    • BMP15 gene dosage as a relevant X-linked determinant of ovarian development and function

      ea0035p646
    • A sensitive method for estrogen profiling in human serum by liquid chromatography-tandem mass spectrometry

      ea0035p647
    • Metabolic fingerprint of serum in first trimester of healthy pregnancy permits the prediction of macrosomia

      ea0035p648
    • Mineral balance, parathormone and vitamin D in patients with policystic ovary syndrome

      ea0035p649
    • Relevance of estrogen activating STS and inactivating SULT1E1 enzymes and estrogen receptors [alpha/beta] in patients with advanced ovarian cancer

      ea0035p650
    • Copeptin in polycystic ovary syndrome

      ea0035p651
    • Inverse relationship between hSHBG affinity for testosterone and hSHBG concentration revealed by surface plasmon resonance

      ea0035p652
    • Evaluation of hormonal pattern and index of oxidative stress in normal weight women with polycystic ovary syndrome

      ea0035p653
    • Ovarian steroid cell tumor not otherwise specified with virilizing manifestations: clinical case

      ea0035p654
    • Dietetic Therapy aimed to restart menstrual period in patients affected by anorexia nervosa in weight recovery

      ea0035p655
    • Valuation of fat tissue distribution in young women with polycystic ovarian syndrome

      ea0035p656
    • Serum leptin concentration in gestational diabetes

      ea0035p657
    • High resolution mass spectrometry to study hormonal regulation of cervical mucus proteome during the menstrual cycle

      ea0035p658
    • ThyrART: a prospective study on thyroid function and autoimmunity during ovarian stimulation for IVF

      ea0035p659
    • Spontaneous fertility and pregnancy outcome in 321 women with Turner syndrome

      ea0035p660
    • Mood disturbances in women with polycystic ovary syndrome

      ea0035p661
    • Demographic characteristics and therapeutical management in patients with primary ovarian insufficiency

      ea0035p662
    • Plasma adhesion molecules concentrations in women with type 1 diabetes mellitus and polycystic ovary syndrome

      ea0035p663
    • The relationship between serum lipocalin-2 levels and insulin resistance in patients with PCOS

      ea0035p664
    • Characterization of the signaling and ovarian functions of bone morphogenetic protein 8

      ea0035p665
    • Does polycystic ovary syndrome influence incidence nonalcoholic fatty liver disease in women?

      ea0035p666
    • Increased prolactin levels cause increased MPV in women with PCOS

      ea0035p667
  • Growth hormone IGF axis basic
  • • Effects of partial deficiency of IGF1 on hepatocellular architecture

      ea0035p668
    • Mechanism of hepatoprotection derived from IGF1 replacement therapy

      ea0035p669
    • Young female with acromegaloid features, pituitary macroadenoma, and an uncomplicated pregnancy

      ea0035p670
    • Epigenetic regulation of GH target genes and its relation to in vivo GH signaling in skeletal muscle of adult human males: a pilot study

      ea0035p671
    • Demographic and clinical characteristics and treatment patterns of polish acromegalic patients switched to lanreotide AUTOGEL 120

      ea0035p672
    • Incidence and late prognosis of acromegaly in Denmark: preliminary data

      ea0035p673
    • Pollution agents contribution in goitrogenous process in dobrogea: the Southeastern boundary of Romania

      ea0035p674
    • The etiologies of growth hormone insufficiences: about 170 cases

      ea0035p675
    • GH replacement therapy affects the morphology and function of the left ventricle in patients with adult-onset GH deficiency

      ea0035p676
    • Positive impact of GH treatment on trabecular bone using grey-level texture analysis

      ea0035p677
    • Analysis of bioactive IGF-binding proteins by quantitative western ligand blotting in different biological fluids for biomarker research

      ea0035p678
    • Latest results from the PATRO Adults study of Omnitrope(R) for the treatment of adult patients with GH deficiency

      ea0035p679
    • Increased relative amount of visceral and subcutaneous adipose tissue in long-lived GH-releasing hormone knockout (GHRHKO) mice; is it beneficial or not?

      ea0035p680
    • Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas

      ea0035p681
    • Evaluation of the effect of X chromosome abnormalities on the response to GH therapy in children with turner syndrome

      ea0035p682
    • The pathophysiology of increased hepatic IGF1 expression in an ovine model of polycystic ovary syndrome

      ea0035p683
  • Male reproduction
  • • The effects of improving testosterone levels on cardiovascular risk markers in young men with idiopathic hypogonadotropic hypogonadism: preliminary findings from a prospective study

      ea0035p684
    • An analysis of the possible relationship circulating concentrations of ghrelin, LH, FSH, testosterone and inhibin B at the time of puberty in normal healthy boys

      ea0035p685
    • Semen quality in patients with newly diagnosed non-Hodgkin lymphoma

      ea0035p686
    • Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome

      ea0035p687
    • Is elevated red blood cell distribution width a new risk factor for polycystic ovary syndrome?

      ea0035p688
    • Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: study during up to 6 years on hypogonadic patients

      ea0035p689
    • The variant FSHB -211G>T attenuates serum FSH levels in the supraphysiological gonadotropin setting of Klinefelter syndrome

      ea0035p690
    • Clinical correlates of enlarged prostate size in subjects with sexual dysfunction

      ea0035p691
    • Clinical implications of measuring prolactin levels in males of infertile couples

      ea0035p692
    • Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples

      ea0035p693
    • Seminal, clinical and color-Doppler ultrasound correlations of prostatitis-like symptoms in males of infertile couples

      ea0035p694
    • Sexual functioning in patients with end-stage liver disease before and after liver transplantation

      ea0035p695
    • Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit

      ea0035p696
    • Metformin in vitro and in vivo increases adenosine signalling in rabbit corpora cavernosa

      ea0035p697
    • Waist circumference and waist-to-height ratio in relation to semen quality and serum reproductive hormones levels among Estonian fertile men

      ea0035p698
    • A possible association between circulating concentrations of obestatin, LH, FSH, testosterone and inhibin B during puberty in normal healthy boys

      ea0035p699
    • 46 XX male syndrome with hypogonadotrophic hypogonadism: a case report

      ea0035p700
    • Gonadal and sexual function in young/middle aged human immunodeficiency virus (HIV)-infected men

      ea0035p701
    • Effect of 17[beta]-estradiol on germ cell apoptosis by modulating the expression of SCF/c-kit, FasL/FasR and regucalcin

      ea0035p702
    • Evaluation of adipocytokine levels and vascular reactivity in hypogonadotropic hypogonadal males

      ea0035p703
    • Current smoking is associated with lower ejaculate and seminal vesicles volume but higher testosterone levels compared to no-smoking in males of infertile couples

      ea0035p704
    • Relationship among nutritional patterns, metabolic parameters and reproductive hormones In healthy young men

      ea0035p705
    • Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction

      ea0035p706
    • Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction

      ea0035p707
    • Regulation of pro-inflammatory cytokines (TNF-[alpha] and IL-6) secretion by LPS in immature rat peritubular cells

      ea0035p708
  • Neuroendocrinology
  • • Identification of the kisspeptin cells of the arcuate nucleus as 'pulse generators' for gonadotropin releasing hormone.

      ea0035p709
    • Meal-induced plasma ghrelin suppression in different phases of anorexia nervosa

      ea0035p710
    • Acromegaly and pregnancy: A descriptive case series

      ea0035p711
    • Papillary thyroid carcinoma associated with silent paraganglioma: An atypical MEN syndrome?

      ea0035p712
    • Copeptin for the differential diagnosis and therapy management of hyponatremia in hospitalized patients - 'The Co-MED-Study'

      ea0035p713
    • Clinical symptoms and characteristics of hospitalized patients with severe hyponatremia

      ea0035p714
    • Clinical manifestations of neurofibromatosis type 1

      ea0035p715
    • Long-term remission and recurrence rates after transsphenoidal surgery for cushing's disease

      ea0035p716
    • A rare incident of gastric mucinous adenocarcinoma in an acromegalic patient

      ea0035p717
    • Bilateral ovariectomy and neurodegeneration

      ea0035p718
    • Effects of pharmacological blockade of glucocorticoids on energy homeostasis control by liver and pancreas in rats without pineal gland

      ea0035p719
    • Copeptin levels measured after pituitary surgery predict later development of diabetes insipidus

      ea0035p720
    • Multiple endocrine neoplasia presenting with a novel mutation on menin gene

      ea0035p721
    • Long-term remission and recurrence rate in a cohort of Cushing's disease: The need for long-term follow-up

      ea0035p722
    • Cinacalcet hydrochloride more efficiently controls serum calcium levels in mild-asymptomatic primary hyperparathyroidism without surgery criteria, as compared with surgical cases

      ea0035p723
    • Treatment of SIADH in a patient with fatal familial insomnia (FFI) and hypersomnia

      ea0035p724
    • If there are differences in postoperative pituitary dysfunction in patients with micro and macroadenomas.

      ea0035p725
    • Radiotherapy or surgical treatment, may affect response of cabergoline in the giant prolactinomas? Report of two cases

      ea0035p726
    • Hyperprolactinemia in women and men

      ea0035p727
    • Changes of metabolic status in children with acquired and congenital multiple pituitary insufficiency

      ea0035p728
    • Poorly differentiated rectal neuroendocrine carcinoma leading to ectopic ACTH syndrome

      ea0035p729
    • The role of intraoperative hormone levels as predictors of Cushing's disease remission

      ea0035p730
    • Influence of the exon 3 deletion of GH receptor and IGF1 level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency

      ea0035p731
    • Hyponatremia in the emergency room of a general teaching hospital: room for improvement

      ea0035p732
    • Prolactinemia and clinical outcome following second generation antipsychotics in early onset schizophrenia

      ea0035p733
    • Efficacy of early postoperative radiotherapy for nonfunctioning null cell or silent pituitary macroadenomas

      ea0035p734
    • Changes in pituitary comorbidities of adult-onset craniopharyngioma depending on date of diagnosis

      ea0035p735
  • Nuclear receptors and signal transduction
  • • Formation of progesterone receptor-NF-[kappa]B complex is required for progesterone-induced NF-[kappa]B nuclear translocation and binding onto the p53 promoter

      ea0035p736
    • The effect of hormone-induced PtdIns (4, 5) P2 depletion on endocytosis suggests the importance of local regulation of inositol lipid signalling

      ea0035p737
    • Thyroid receptors antagonizes TGF[beta] actions in vivo and in culture cells

      ea0035p738
    • Increased irisin abundance in muscle and blood circulation after treadmill exercise in mice

      ea0035p739
  • Obesity
  • • Bariatric surgery in Prader-Willi syndrome

      ea0035p740
    • Effects of depressive symptoms on clinical outcomes, inflammatory markers and quality of life after a significant weight loss in a bariatric surgery sample

      ea0035p741
    • Clinical associations of perceived well-being in obese subjects: a focus on laboratory measurements

      ea0035p742
    • Profile of patients treated in our 'eating disorders unit' from 1996 to the present

      ea0035p743
    • The mRNA levels of TNF[alpha], Omentin-1 and PPAR[gamma] in adipose tissue of patients with abdominal obesity

      ea0035p744
    • The efficacy and safety of 12 weeks Anethum graveolens on waist circumference and triglyceride in patients with metabolic syndrome

      ea0035p745
    • Modification in the expression of peripheral appetite signals during hypoxia exposure contributes to anorexia

      ea0035p746
    • Accumulation of abdominal fat in relation to selected proinflammatory cytokines concentrations in non obese Wroclaw inhabitants

      ea0035p747
    • Bariatric surgery and bone loss: novel mechanisms and comparison of different modalities

      ea0035p748
    • The effects of octreotide acetate long-acting repeatable (LAR) on mean platelet volume in acromegaly: octreotidelar may have a detrimental effect on MPV, a new indicator of atherosclerosis

      ea0035p749
    • Leptin evolution in Aves

      ea0035p750
    • Level of knowledge about type 1 diabetes mellitus among nurses employed at endocrinological dispensaries

      ea0035p751
    • Adiponectin upregulates SHBG production: molecular mechanisms and potential implications

      ea0035p752
    • Correlates of visceral and subcutaneous fat thickness in non-diabetic obese and morbidly obese patients

      ea0035p753
    • Meaningful and sustained weight loss and improvement of lipid profile in hypogonadal men on long-term treatment with testosterone undecanoate (TU) injections are independent of age: observational data from two registry studies

      ea0035p754
    • Anthropometric and metabolic parameters in 46 hypogonadal men with obesity grade III improve upon long-term treatment with testosterone undecanoate (TU) injections: Observational data from two registry studies

      ea0035p755
    • Unstandardized meal does not affect plasma concentrations of leptin, acylated and des-acylated ghrelin in humans

      ea0035p756
    • Circulating endocannabinoids are associated with cardiometabolic impairment independently of adiposity in normal weight subjects

      ea0035p757
    • Irisin plasma concentration in PCOS and healthy subjects is related to body adipose content

      ea0035p758
    • May the FTO gene affect visceral obesity? Study of variant rs9930506 SNP among the MONW in a Polish population

      ea0035p759
    • Worsening of cardiovascular risk with increasing number of components of metabolic syndrome in obese non-diabetic individuals

      ea0035p760
    • Health-related quality of life relates to obesity and low-grade inflammation in obese individuals

      ea0035p761
    • Higher serum levels of the Wnt-signaling antagonist DKK1 in obese respect to Prader-Willi syndrome

      ea0035p762
    • Evaluation of the prevalence of obesity in Minsk city

      ea0035p763
    • Improvement of type 2 diabetes after gastric banding and gastric bypass: medium-term outcomes

      ea0035p764
    • GLP-1, insulin and glucose levels during mixed test meal before and after gastric bypass surgery in obese patients

      ea0035p765
    • Vertebral bone marrow fat is increased in obese women: relationship with epicardial fat

      ea0035p766
    • Abstract unavailable

      ea0035p767
    • Serum orexin-A levels, insulin resistance and sleep problems in metabolic syndrome

      ea0035p768
    • Relationship of serum TSH with BMI, weight and HOMA-IR in euthyroid obese subjects

      ea0035p769
    • GLP1 analogs as treatment of postprandial hypoglycemia after gastric bypass for morbid obesity

      ea0035p770
    • Adipocyte fatty acid binding protein (A-FABP) deficiency promotes diet-induced obesity partially via its regulation on adaptive thermogenesis

      ea0035p771
    • Offspring of parents with obesity complex investigations: risk of carbohydrate disturbances and diabetes

      ea0035p772
    • Downregulation of complement C3 and C3aR expression in subcutaneous adipose tissue in obese Caucasian women

      ea0035p773
    • Stimulation of cystatin C production in adipocytes by insulin, GH and triiodothyronine (T3)

      ea0035p774
    • Free vs total testosterone as a marker of Leydig cell function and androgen exposure in obese male adolescents

      ea0035p775
    • Application of LC-MS and CE-MS based metabolomics to study type 2 diabetes development in lean, overweight and obese humans

      ea0035p776
    • The outcome results in patients with type 2 diabetes mellitus and obesity after either adjustable gastric banding (AGB) or Roux-en-Y (RNY) gastric bypass

      ea0035p777
    • Association analysis of the D2 dopamine receptor gene Taq IA polymorphisms in a cohort of Belarus morbidly obese children and adolescents.

      ea0035p778
    • The adaptor protein APPL2 acts as a central regulator of energy metabolism

      ea0035p779
    • Adiposity changes show primacy over the effect of insulin sensitivity changes on androgen profile in obese men integrating short-term weight loss programs

      ea0035p780
    • Hyperleptinemia and insulin resistance in obesity-associated sleep apnoea: Sex-dependent effects of CPAP application

      ea0035p781
    • Use of visceral fat percentage and body fat percentage compared to anthropometric parameters in predicting obesity and cardiovascular risk in Sri Lankan population

      ea0035p782
    • Decreased expression of genes encoding thermogenesis-related proteins in adipose tissues of obese patients is not associated with their methylation status

      ea0035p783
    • Different relationship between serum 25OH-vitamin D and expression of vitamin D 25-hydroxylase gene CYP2R1 in subcutaneous adipose tissue of obese and slim subjects.

      ea0035p784
    • Adiponectin gene expression in subcutaneous and deep neck adipose tissue

      ea0035p785
    • Change in cardiovascular risk factors Following bariatric surgery for obesity - First Sri Lankan experience

      ea0035p786
    • The association between metabolic syndrome and android fat mass and android to gynoid fat mass ratio- are Classification and Regression Trees models helpful?

      ea0035p787
    • Dietary fat alters the expression of cortistatin and ghrelin systems in the PBMCs of elderly subjects: Putative implications in the postprandial inflammatory response

      ea0035p788
    • Climate and risk of obesity: [email protected] study

      ea0035p789
    • Sex hormone binding globulin, total and HMW adiponectin and insulin resistance among normal weight postmenopausal women with metabolic syndrome

      ea0035p790
    • Childhood obesity alters innate T cell frequency and function resulting in loss of regulation and increased inflammation

      ea0035p791
    • Metabolic and hypertension control in diabetic patients submitted to bariatric surgery

      ea0035p792
  • Paediatric endocrinology
  • • Effectiveness of GH therapy in children with normal results of GH stimulation tests and with partial GH deficiency is similar and depends on the severity of IGF1I deficiency

      ea0035p793
    • Inflammation: a risk factor or a consequence of metabolic diseases in obese prepubertal Iraqi children

      ea0035p794
    • A case of velocardiofacial syndrome with short stature associated with partial GH deficiency

      ea0035p795
    • Kearn-Sayre syndrome associated with adenohypophysis agenesis: long term follow-up

      ea0035p796
    • A new cause of liver cirrohosis in childhood: Long-term uncontrolled obesity

      ea0035p797
    • Delayed puberty in a girl with ataxia telangiectasia: Multiple endocrine dysfunctions

      ea0035p798
    • Vitamin D assessment in infants with prolonged hospitalisation

      ea0035p799
    • Small for gestational age (SGA) children: Results after 3 years of GH therapy

      ea0035p800
    • The longitudinal study of replacement therapy of secondary hypothyroidism in newborn with brain damage

      ea0035p801
    • Causes of short stature in endocrinology: about 800 cases

      ea0035p802
    • Characteristics of nutritional status in children with alimentary obesity

      ea0035p803
    • Perinatal risk factors of the development of obesity in children

      ea0035p804
    • Morbidity dynamics of diabetes in children living in the West region of Belarus

      ea0035p805
    • 25-Hydroxyvitamin D concentrations before and in the 1st year of GH treatment in relation to height velocity, IGF-1 and bone age

      ea0035p806
    • Usefulness of ACTH stimulation in the differential diagnosis of precocious pubarche

      ea0035p807
    • Peculiarities of emotional disorders in children with obesity

      ea0035p808
    • Emotional and binge eating disorders in children with severe obesity

      ea0035p809
    • Effect of microelement imbalance on the thyroid function in children

      ea0035p810
    • Further molecular characterization of a novel neurodegenerative syndrome associated to a mutation in the Seipin/BSCL2 gene

      ea0035p811
    • Pediatric Graves disease: treatment options and prognosis factors

      ea0035p812
    • Polycystic ovary syndrome in overweight and obese adolescent girls and its association with insulin resistance and metabolic syndrome

      ea0035p813
    • Differences in skeletal development and growth in children with Noonan syndrome

      ea0035p814
    • Short stature and carnitine deficiency: the hidden connection

      ea0035p815
    • Nonalcoholic fatty liver disease in obese children

      ea0035p816
    • Hormone and metabolic profile of diabetic adolescent girls with menstrual disorders

      ea0035p817
    • Analysis of Th17 cells and IL17, IL23 cytokines in peripheral blood from children with autoimmune thyroid disease

      ea0035p818
    • Pseudohypoparathyroidism: challenging diagnosis due to autism and epileptic seizures

      ea0035p819
    • Anti-oxidation improves in early puberty in normal weight and obese boys, in positive association with exercise stimulated GH secretion

      ea0035p820
    • Molecular findings of three different male under virilization cases with 47,XXY karyotype

      ea0035p821
    • Achondroplasia and neurological complications

      ea0035p822
    • Pediatrics cushing disease: a diagnostic challenge

      ea0035p823
    • Metabolic repercussion of growth hormone deficiency in the child and adolescent

      ea0035p824
    • Medication safety study investigating hydrocortisone individually and extemporaneously compounded capsules for paediatric use in congenital adrenal hyperplasia

      ea0035p825
  • Pituitary Basic (Generously supported by IPSEN)
  • • Copeptin concentrations increase during glucagon stimulation test: possible role of copeptin in assessment of anterior pituitary function

      ea0035p826
    • Effect of ubiquitin/proteosome inhibition on acth secretion by rat corticotropes

      ea0035p827
    • Different expression of prolactin receptor gene in rat duodenum during physiological and medicamentous hyperprolactinemia

      ea0035p828
    • Prothymosin alpha and Ki-67 expression in pituitary adenomas

      ea0035p829
    • Dopamine receptor type 2 (dopamine receptor type 2) inhibits non-functioning human pituitary tumor-derived cell line HP75 migration through ROCK-mediated cofilin inactivation

      ea0035p830
    • Functional characterization of a new deletion in CDKN1B 5'-UTR region

      ea0035p831
    • Correlation of coexpression of pituitary genes in QPCR and microarray study in pituitary adenomas

      ea0035p832
    • Germline aryl hydrocarbon receptor interacting protein (AIP) gene mutations in patients with apparently sporadic pituitary macroadenomas (PMA): initial results

      ea0035p833
    • Expression of peroxisome-proliferator activated receptor [alpha] in pituitary tumours

      ea0035p834
    • AIP expression in non-functioning pituitary adenomas is strongly associated with the gonadotroph phenotype but not with tumour aggressiveness

      ea0035p835
    • Survivin expression in invasive pituitary gland adenomas with a diameter exceeding 20 mm

      ea0035p836
  • Pituitary Clinical (Generously supported by IPSEN)
  • • Evolution of the glucidic metabolism disorders in the acromegalia

      ea0035p837
    • Clinical features and therapeutic outcomes of acromegaly during the recent 5 years: single centre experience

      ea0035p838
    • Thyrotropinoma: one tumour, two different clinical presentations

      ea0035p839
    • TSH-secreting pituitary adenomas: a rare cause of hyperthyroidism

      ea0035p840
    • Demographical and clinical characteristics of 62 acromegalic patients

      ea0035p841
    • Clinical evaluation of follow-up of 62 patients: do treatment methods in acromegaly affect the rates of cure and hypophyseal insufficiency?

      ea0035p842
    • Improvement of quality of life in acromegalic patients evaluated by AcroQoL in Korea

      ea0035p843
    • Enormous, LH secreting gonadotroph adenoma in a male patient

      ea0035p844
    • NFPA and hypopituitarism: a retrospective analysis of 260 patients and focus on the prevalence of isolated hypoadrenalism

      ea0035p845
    • Resolution of severely impaired cognitive function following medical treatment of cystic invasive giant prolactinoma

      ea0035p846
    • TSH-secreting pituitary adenoma treated conservatively with cabergoline for more than 10 years

      ea0035p847
    • An audit of hyponatraemia in a large UK university teaching hospital

      ea0035p848
    • A statistical model of patient satisfaction after surgery for non-functioning macroadenomas of the pituitary gland

      ea0035p849
    • Endocrine abnormalities in primary empty sella

      ea0035p850
    • What is in the sella while spying on cancer? The role of FDG-PET/CT in differential diagnosis of sellar mass during staging for malignant disease

      ea0035p851
    • Lymphocytic hypophysitis: natural history and management in the 21st century

      ea0035p852
    • Assessment of the hypothalamus-pituitary-adrenal axis with different corticotropin tests in adult patients with Prader-Willi syndrome

      ea0035p853
    • Mean platelet volume in male hypogonadotropic hypogonadysm: the relationships among with MPv, low testosterone levels, metabolic syndrome, impaired fasting glucose and cardiovascular risk

      ea0035p854
    • The effects of octreotide acetate long-acting repeatable on mean platelet volume in acromegaly: octreotidelar may have a detrimental effect on MPV, a new indicator of atherosclerosis

      ea0035p855
    • GH replacement therapy during pregnancy in a patient with Sheehan's syndrome

      ea0035p856
    • Constipation in elderly men, the initial manifestation of empty sella

      ea0035p857
    • A case of IgG4-related xanthomatous hypophysitis

      ea0035p858
    • Pituitary abnormalities in short adolescents and young adults with sickle-cell disease and recurrent vaso-occlusive crisis

      ea0035p859
    • Evolution of glucose tolerance status after treatment of acromegaly: a prospective study in 57 patients

      ea0035p860
    • Serum prolactin in advanced chronic liver disease

      ea0035p861
    • Assessment the relationship between TSH and selected anthropometric parameters: preliminary report

      ea0035p862
    • Is pregnancy possible with acromegaly?

      ea0035p863
    • A case of lymphocytic hypophysitis presented as hemorrhagic pituitary macroadenoma

      ea0035p864
    • Effect of chronic treatment with cabergoline and testosterone replacement on metabolic parameters in male patients with prolactinomas and hypogonadism

      ea0035p865
    • A middle aged woman with isolated ACTH deficiency associated with transient GH deficiency

      ea0035p866
    • Sterile pituitary abscess associated with hypophysitis and panhypopituitarism: case report

      ea0035p867
    • Pathological findings in kidneys of acromegalic patients

      ea0035p868
    • A case with acromegaloidism

      ea0035p869
    • Colon cancer metastatic to the pituitary gland: a case report

      ea0035p870
    • Acut monocytic leukemia with pituitary involvement; a case report

      ea0035p871
    • Late onset postpartum diabetes insipidus: a case report

      ea0035p872
    • Abnormalities of midline and GH deficiency: about 160 cases

      ea0035p873
    • Acromegaly and schizophrenia: an incidental association?

      ea0035p874
    • Pre-surgical medical treatment, a major prognostic factor of remission in acromegaly

      ea0035p875
    • Preoperative octreotide treatment of acromegaly: long-term results of a randomized, controlled study

      ea0035p876
    • A case with macroprolactinemia and gigantomastia responding to cabergoline treatment

      ea0035p878
    • Comprehensive geriatric assessment of elderly cases with acromegaly

      ea0035p879
    • Somatostatin analogue treatment of a TSH secreting adenoma presenting with accelerated bone metabolism and a pericardial effusion

      ea0035p880
    • Normal health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment

      ea0035p881
    • Comparison of the effectiveness of bromocriptine and cabergoline treatment of microprolactinomas in women based on results of dynamic pituitary gland MRI

      ea0035p882
    • A case of become pregnant woman with active acromegaly during Octreatide LAR treatment

      ea0035p883
    • Register of sellar tumors: RESET: diagnostics and therapy of acromegaly in Czech and Slovak Republics

      ea0035p884
    • Study Design of a Phase II trial of pasireotide s.c. alone or in combination with cabergoline in patients with Cushing's disease

      ea0035p885
    • An acromegalic patient with history of renal transplantation

      ea0035p886
    • Anterior and posterior pituitary functions in male prolactinomas

      ea0035p887
    • Hyperprolactinemia and chiasmic syndrome in patients with non functioning pituitary tumors

      ea0035p888
    • Acromegalic arthropathy: clinical presentation, treatment and quality of life

      ea0035p889
    • Analysis of metabolic alterations within the normal appearing brain in children with GH deficiency: MR spectroscopy and hormonal correlation

      ea0035p890
    • Pituitary non-secreting micro-incidentalomas and endocrine dysfunctions: a retrospective analysis in 236 Romanian patients

      ea0035p891
    • Pituitary incidentaloma: an age-related study in 266 Romanian patients

      ea0035p892
    • Post-partum pituitary insufficiency: diagnostic challenge

      ea0035p893
    • 'High dose hook effect' in a patient with invasive giant prolactinoma

      ea0035p894
    • Six cases of FSH/LH positive pituitary adenomas

      ea0035p895
    • Long-term efficacy and withdrawal of octreotide LAR in acromegaly patients, a prospective single centre study with 4 years follow-up

      ea0035p896
    • A case of an isolated ACTH deficiency who had a prolonged QT interval

      ea0035p897
    • Recurrence of hyperprolactinemia after withdrawal of cabergoline in prolactinomas

      ea0035p898
    • Langerhans cell histiocytosis: a case report

      ea0035p899
    • Diabetes insipidus secondary to hypothalamus and pituitary metastasis

      ea0035p900
    • How to get surgical remission rates in ACTH-microadenomas close to 100% using minimally invasive approaches for diagnosis and surgery

      ea0035p901
    • Prolactin hyperproduction does not predict the risk of glucose metabolic disturbances in patients with acromegaly

      ea0035p902
    • Cushing's disease: the dynamics of serum cortisol concentrations after successful transsphenoidal surgery and the restoration of the adrenal cortex function

      ea0035p903
    • Alternative method of macroprolactin evaluation as a cause of hyperprolactinaemia

      ea0035p904
    • Effect of pasireotide on GH, IGF1, IGFBP2, IGFBP3, HbA1C and glucose in patients with inadequately controlled acromegaly: exploratory results from a multicentre, randomized, 24-week study (PAOLA)

      ea0035p905
    • Somatostatin analogues treatment did not modify glucose control in acromegalic, diabetic subjects

      ea0035p906
    • Pasireotide LAR demonstrates superior efficacy versus octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: results from a phase III, multicentre, randomized study (PAOLA)

      ea0035p907
    • High prevalence of autoimmune thyroid diseases in females with prolactinomas: results from a cross-sectional case-control prospective study in a single tertiary referral centre

      ea0035p908
    • Hormonal deficiency in patients with craniopharyngioma

      ea0035p909
    • Relationship between early and longer-term tumour volume reduction (TVR) with primary lanreotide Autogel (LAN-ATG) therapy in treatment-naive acromegalic patients: post hoc analyses of the PRIMARYS study

      ea0035p910
    • Tumour and hormonal response with lanreotide Autogel 120 mg in treatment-naive acromegalic patients: further post hoc data from the PRIMARYS study

      ea0035p911
    • Efficacy and safety of lanreotide autogel (LAN-ATG) 120 mg at extended dosing intervals (EDIs) in acromegalic patients biochemically controlled with octreotide LAR (OCT-LAR) 10 or 20 mg: The LEAD study

      ea0035p912
    • Cortisol metabolites response in hypothalamic-pituitary-adrenal axis tests

      ea0035p913
    • Octreotide fluid crystal provides sustained octreotide bioavailability and similar IGF1 suppression to that of octreotide LAR (Sandostatin LAR): randomized, open-label, Phase I, repeat-dose study in healthy volunteers

      ea0035p914
    • Clinical case: Silent corticotroph pituitary macroadenoma transforming into Cushing disease.

      ea0035p915
    • Lanreotide-induced bradycardia and supraventricular extrasystoles

      ea0035p916
    • Treating prolactinoma by endoscopic endonasal pituitary surgery: surgical experience of 151 cases

      ea0035p917
    • Pharmacokinetic (PK) and pharmacodynamic (PD) analyses of pasireotide LAR and octreotide LAR: Randomized, double-blind Phase III study in patients with medically naive acromegaly

      ea0035p918
    • Copeptin in basal conditions and during water deprivation test in patients with polydipsic-polyuric disorders

      ea0035p919
    • A case or recurrent pituitary apoplexy

      ea0035p920
    • Increased prevalence of differentiated thyroid carcinoma in patients with acromegaly

      ea0035p921
    • Oral and dental pathologies in patients with acromegaly

      ea0035p922
    • Relationship between growth hormone deficiency and oxidative stress in patients with heart failure: Preliminary data.

      ea0035p923
    • GH Deficiency in HIV-infected patients compared to hypopituitary patients

      ea0035p924
    • Conservative management of pituitary apoplexy - own experience

      ea0035p925
    • Pituitary apoplexy: surgical or conservative management

      ea0035p926
    • Histiocytosis of pituitary gland: a case report

      ea0035p927
    • Diabetes inspidus post traumatic head injury

      ea0035p928
    • Malignancies in patients with pituitary adenomas

      ea0035p929
    • Psychosocial changes in patients with acromegaly: the preliminary results

      ea0035p930
    • Population-based cohort study: PROP1 gene mutations are the most prevalent cause of congenital multiple pituitary hormone deficiency in Lithuania

      ea0035p931
    • Cabergoline-induced pneumocephalus: an unusual complication of macroprolactinoma treatment

      ea0035p932
    • An unusual cause of hypopituitarism

      ea0035p933
    • Russian registry of patients with tumors of the hypothalamic-pituitary region (OGGO): October 2013 update for acromegaly

      ea0035p934
    • Prevalence of thyroid dysfunction in naive acromegalic patients

      ea0035p935
    • Dilated cardiomiopathy and acromegaly

      ea0035p936
    • IGF1 response to rhGH in adult GHD: role of GH receptor (GHR) isoforms

      ea0035p937
    • Markers of proliferation and invasion in somatotropinomas

      ea0035p938
    • Individual risk factors of metabolic syndrome in adult patients with GH deficiency: a cross-sectional case-control study

      ea0035p939
    • Assessment of glucose homeostasis alterations, inflammatory markers, and coagulation parameters following a successful transsphenoidal surgery for Cushing's disease: preliminary report.

      ea0035p940
    • Determinants of survival in treated patients with acromegaly

      ea0035p941
    • Surgical treatment of ACTH-secreting pituitary adenomas in nelson syndrome

      ea0035p942
    • The impact of the Cushing's Disease remission in associated comorbidities

      ea0035p943
    • Weight and metabolic profile evolution in patients with treated prolatinomas

      ea0035p944
    • Cushing's disease caused by atypical pituitary adenoma

      ea0035p945
  • Steroid metabolism and action
  • • Measurement of testosterone, androstenedione and dehydroepiandrosterone (DHEA) serum levels using isotope-dilution liquid-chromatography tandem mass spectrometry (ID-LC-MS/MS)

      ea0035p946
    • Vitamin D is associated with androgen synthesis in human testicular cells

      ea0035p947
    • Changes in serum steroid concentrations in relation to fat distribution and insulin resistance in women with polycystic ovarian syndrome

      ea0035p948
    • The role of steroid hormones in the development of postpartum depression

      ea0035p949
    • Tissue cortisol vs lipolysis in ICU patients

      ea0035p950
    • Testosterone stimulates glucose uptake in HepG2 liver cells

      ea0035p951
    • A hypercoagulable state associated with intravenous pulse methylprednisolone (MP) therapy in patients with Graves' orbitopathy

      ea0035p952
    • Adrenal androgen secreting tumour in 39-year-old woman: Hormones and sexuality

      ea0035p953
    • Estradiol and its metabolite 2-methoxyestradiol modulate the growth of HECa10 line acting predominantly in the opposite way

      ea0035p954
    • Testosterone supplementation and sexual function: a meta-analysis study

      ea0035p955
    • Profiling of neuroactive steroids, their precursors and metabolites in patients suffering from multiple sclerosis

      ea0035p956
    • Role of clinical risk factors and polymorphisms in glucocorticoid receptor gene in the determining the risk of developing new-onset diabetes after kidney transplantation

      ea0035p957
  • Thyroid (non-cancer)
  • • A case of primary hypothyroidism: Lingual thyroid

      ea0035p958
    • Urinary iodine excretion in Egyptian females with nodular goiter

      ea0035p959
    • The FRAX score in postmenopausal women with subclinical hyperthyroidism

      ea0035p960
    • Graves' disease presented with renal infarction

      ea0035p961
    • Female cardiothyrosis

      ea0035p962
    • Male cardiothyrosis

      ea0035p963
    • Abstract unavailable

      ea0035p964
    • Quality of life is impaired in patients with euthyroid nodular goiter

      ea0035p965
    • Thyrotoxic periodic paralysis as the first manifestation of hyperthyroidism

      ea0035p966
    • Usefulness of color-flow doppler ultrasonography in the differential diagnosis of thyrotoxicosis in outpatients

      ea0035p967
    • Evaluation of epicardial adipose tissue thickness in patients with overt hyperthyroidism

      ea0035p968
    • Evolution of thyroid function in Hashimoto's thyroiditis and related disorders-January 2014

      ea0035p969
    • Immune associations in chronic thyroiditis - January 2014

      ea0035p970
    • Relationships between antithyroperoxydase antibody and antithyroglobulin antibody levels with thyroid function in chronic thyroiditis - January 2014

      ea0035p971
    • Efficacy of different models for explaining the endocrine surgery operative procedure

      ea0035p972
    • Hyperprolactinaemia in patients with hypothyroidism

      ea0035p973
    • Management of hypothyroidism in pregnancy

      ea0035p974
    • Pregnancy outcomes in women with subclinical hypothyroidism

      ea0035p975
    • Serum C-reactive protein level is a better indicator than erythrocyte sedimentation rate in assessing the severity of inflammation before initiation of glucocorticoid therapy in the sub acute thyroiditis patients

      ea0035p976
    • Body mass analysis in patients with Hashimoto thyroiditis

      ea0035p977
    • Body mass analysis in patients with Hashimoto thyroiditis

      ea0035p978
    • Ultrasound-guided thyroid fine needle aspiration with rapid on-site evaluation of adequacy: data from the clinic of endocrinology of a Greek tertiary general hospital in 2013

      ea0035p979
    • An ectopic thyroid tissue presenting as anterior mediastinal mass in a breast cancer patient

      ea0035p980
    • Hyperthyroidism in a pregnant woman who had hypothroidism due to Hashimoto disease before

      ea0035p981
    • Treatment of severe thyroid function disorders and observed changes in body composition

      ea0035p982
    • Role of conventional ultrasonography and shear wave elastography in selection lesions for fine needle aspiration biopsy in multinodular goiter - preliminary study

      ea0035p983
    • Does iodine status have an impact on thyroid parameters in healthy pregnant women during the first trimester?

      ea0035p984
    • This is why we recommend the screening for hypothyroidism in pregnant women

      ea0035p985
    • Polymorphisms within genes encoding co-stimulatory molecules modulate the susceptibility to Graves' disease and orbitopathy

      ea0035p986
    • Comparison of aspiration vs with-out aspiration fine-needle biopsy of thyroid nodules for adequacy of cellularity according to Bethesda system

      ea0035p987
    • Long-term efficacy of ultrasound-guided laser ablation for solid thyroid nodules. A three-year multicenter prospective randomized trial

      ea0035p988
    • Radio frequency ablation (RFA) and percutaneous laser ablation (PLA) in the treatment of thyroid nodules under ultrasound (US) guidance: Preliminary evaluation

      ea0035p989
    • The prevalence of coexistence thyroid carcinoma and thyroid nodules in hyperthyroid patients of San Juan City Hospital

      ea0035p990
    • Multifocal sclerosing thyroiditis: a case report

      ea0035p991
    • Virtually-tracked US-guided radio frequency ablation of benign thyroid nodules: preliminary evaluation

      ea0035p992
    • Mean platelet volume in euthyroid patients with Hashimoto's thyroiditis

      ea0035p993
    • Frequency of isolated maternal hypothyroxinemia at gestational diabetes mellitus

      ea0035p994
    • Hyperthyroidism one of the cause of pulmonary hypertension

      ea0035p995
    • Irisin - newly discovered adipo-myokine and its association with thyroid function - preliminary study

      ea0035p996
    • Thyroid function during pregnancy

      ea0035p997
    • FT3 level is a predictor of mortality in hemodialysis patients in 5 years follow-up

      ea0035p998
    • Serum leptin levels among women with and without autoimmune thyroid disease in euthyroid state

      ea0035p999
    • Delayed puberty and early menopause in women with GH deficiency

      ea0035p1000
    • Amyloid goiter as an unusual presentation of primary systemic amyloidosis: A case report

      ea0035p1001
    • Thyroid disorders in systemic lupus erythematosus: Influence of hypothyroidism on clinical manifestations and analytical parameters

      ea0035p1002
    • Relationship between hypothyroidism and autoimmunity in systemic lupus erythematosus patients: An initial approach

      ea0035p1003
    • Thyroid disorders in adults after oncologic treatment in childhood

      ea0035p1004
    • Iodine deficiency in Belarus: state of the problem

      ea0035p1005
    • A case with silent thyroiditis accompanied by repeated deep vein thrombosis

      ea0035p1006
    • The metabolic syndrome, and not obesity, is associated with fasting TSH in euthyroid obese children and adolescents

      ea0035p1007
    • Recurrence of Graves' disease after radioiodine treatment: factors related to treatment failure

      ea0035p1008
    • Severe side effects of methimazole in the treatment of hyperthyroidism

      ea0035p1009
    • Proteomic analysis of thyroid tissue in Graves' disease and toxic multinodular goiter

      ea0035p1010
    • Hyperglycaemia in hypothyroidism

      ea0035p1011
    • May dental extraction trigger subacute thyroiditis?

      ea0035p1012
    • Anti-C1q autoantibodies are linked to autoimmune thyroid disorders in pregnant women.

      ea0035p1013
    • Whether various ways of quality of life answer rank-transformation influence on final score and grouping among hypothyroid patients?

      ea0035p1014
    • Differences in genetic predisposition to Graves' disease and Graves' orbitopathy between young and elderly patients

      ea0035p1015
    • Different therapeutic outcomes in two cases with active moderate-to-severe Graves'orbitopathy treated with intravenous steroid therapy-case presentation

      ea0035p1016
    • Adipokines and cardiovascular risk factors in patients with autoimmune thyroiditis and subclinical hypothyroidism

      ea0035p1017
    • Oxidative stress in patients with Basedow-Graves' disease

      ea0035p1018
    • Oral solution of levothyroxine vs tablets in subclinical hypothyroidism: evaluation of outcomes

      ea0035p1019
    • Hematological disorders in hypothyroidism: about a series of 100 cases

      ea0035p1020
    • Vitamin D levels in autoimmune thyroiditis and a control group among the Polish population

      ea0035p1021
    • Abstract unavailable

      ea0035p1022
    • Is Clinical Activity Score (CAS) a sufficient indicator of the response to therapy with i.v. methylprednisolone (MP) and external radiotherapy (RT) for Graves orbitopathy?

      ea0035p1023
    • A case of thyrotoxic hypokalemic periodic paralysis presenting with 'U' wave on ECG

      ea0035p1024
    • Does radioactive iodine ablation treatment in patients with hyperthyroidism effect on glucose metabolism?

      ea0035p1025
    • Nutriciological monitoring of iodine status as a measure of iodine deficiency prevention

      ea0035p1026
    • DHEAS Levels in Obese Patients with Hashimato Thyroiditis

      ea0035p1027
    • The role of peroxisome proliferator-activated receptors [alpha] polymorphisms in Graves' disease and orbitopathy

      ea0035p1028
    • Mediastinal goiter: a rare cause of dyspnea, chest and back pain

      ea0035p1029
    • Infliximab-induced destructive thyroiditis followed by hypothyroidism: a case report

      ea0035p1030
    • An increase in the circulating concentrations of triiodothyronine appears to be a function of the peripheral conversion of tetraiodothyronine by deiodinases instead of increased stimulation by thyroid stimulating hormone at puberty in normal healthy boys

      ea0035p1031
    • Interplay between ghrelin, obestatin, leptin and triiodothyronine that possibly regulate energy metabolism during the time of puberty in normal healthy boys

      ea0035p1032
    • Obesity and metabolic syndrome in patients with primary acquired hypothyroidism undergoing chronic LT4 replacement therapy

      ea0035p1033
    • A descriptive study on individually titrated levothyroxine in the management of South African hypothyroid patients (DeuTSH)

      ea0035p1034
    • Results of preventive radioiodine therapy in euthyroid patients with history of hyperthyroidism prior to administration of amiodarone with permanent atrial fibrillation (preliminary study)

      ea0035p1035
    • A case with suppurative thyroiditis caused by salmonella infection

      ea0035p1036
    • Grave's disease as an adverse effect of ipilimumab: first description of two cases

      ea0035p1037
    • Thyroglobulin as a biomarker of iodine deficiency

      ea0035p1038
    • Abstract unavailable

      ea0035p1039
    • Quality of life and the psychoemotional status of the patients after radical treatment of Graves' disease

      ea0035p1040
    • The induction of hyperthyroidism in patient with non-toxic goiter after radioiodine therapy: a case report

      ea0035p1041
    • Antithyroid drug-induced agranulocytosis: experience of the French centers of Pharmacovigilance with a retrospective study of more than 200 cases

      ea0035p1042
    • Quality of life of patients with hypothyroidism

      ea0035p1043
    • ThyPROpl: the polish version of the thyroid-specific quality of life questionnaire ThyPRO

      ea0035p1044
    • Evaluation of risk of hypothyroidism in pregnant women with overweight and obesity

      ea0035p1045
    • Amiodarone induced thyrotoxicosis, a difficult cases report

      ea0035p1046
    • Study of thyroid function during pregnancy in a random population of Northern Greece

      ea0035p1047
    • Adherence of levothyroxine treatment in primary hypothyroid patients in Turkey: a multicenter study

      ea0035p1048
    • Thyroid hormone concentration and ultrasonographic findings in middle-aged lithuanian males and females from general population

      ea0035p1049
    • Selective embolization thyroid artery as a treatment for Graves' disease

      ea0035p1050
    • Postoperative monitoring and replacement therapy after resection of the thyroid gland

      ea0035p1051
    • Prevalence of thyroid dysfunction and thyroid auto-antibodies among persian pregnant women

      ea0035p1052
    • Thyroid volume in adult [beta]-thalassemic patients is smaller than in controls

      ea0035p1053
    • Steroid treatment in patients with active moderate-to-severe Graves orbitopathy

      ea0035p1054
    • The influence of radioiodine therapy in 1600 patients with subclinical hyperthyroidism

      ea0035p1055
    • Hydrolytical activity of autoantibodies to double-stranded DNA in autoimmune thyroiditis

      ea0035p1056
    • Analysis of chosen polymorphisms in FoxP3 gene in children and adolescents with autoimmune thyroid diseases

      ea0035p1057
    • The clinical values of IGF1 and IGF-binding protein-3 levels in blood and thyroid nodules

      ea0035p1058
    • Voluntary supplementation does not fully correct iodine deficiency among Latvian pregnant women: a national cross-sectional survey

      ea0035p1059
    • THRB expression is affected by miR-26a and miR-496, but age-associated decrease of the expression of this gene in human peripheral blood mononuclear cells is not dependent on these miRNAs

      ea0035p1060
    • Hyperthyroidism during pregnancy: the role of measuring maternal TSH receptor antibodies and fetal ultrasound monitoring

      ea0035p1061
    • High mean platelet volume in hyperthyroid patients after radioactive 131I treatment

      ea0035p1062
    • Inferior oblique muscle enlargement in a patient with Grave's orbitopathy

      ea0035p1063
    • Solitary autonomously functioning thyroid nodule and severe osteoporosis

      ea0035p1064
    • Assessment of thyroid function and volume in hypogonadal patients

      ea0035p1065
    • MRI evaluation of extraocular muscles in patients with Grave's orbitopathy

      ea0035p1066
    • Successful preoperative treatment of toxic nodular goiter patient with agranulocytosis using plasmapheresis

      ea0035p1067
    • The lipid profile in patients with subclinical hypothyroidism and metabolic syndrome

      ea0035p1068
    • Hypertensive patients with mild hypothyroidism show less frequent spontaneous normalization of thyroid function than normotensive patients

      ea0035p1069
    • Ultrasound thyroid imaging, TSH and anti-thyroid peroxidase antibodies concentrations in Warsaw adolescents: the influence of family history of thyroid disease: preliminary results

      ea0035p1070
    • Prevalence of subclinical hypothyroidism among girls attending the gymnasia in the city of Starogard Gdanski

      ea0035p1071
    • Antiepileptic drugs and the thyroid hormone axis

      ea0035p1072
    • Hyperthyroidism in a pregnant, previously hypothyroid patient

      ea0035p1073
    • High-resolution thyroid nodule clinic: analysis of 1674 thyroid nodules

      ea0035p1074
    • Cardiothyreosis in female with overt hyperthyroidism

      ea0035p1075
    • Therapeutic options for Grave's disease and toxic nodular disease: experience of an endocrinology department

      ea0035p1076
    • A typical clinical manifestations of Graves' disease

      ea0035p1077
    • Evaluation of cardiovascular risk factors in adults with primary hypothyroidism

      ea0035p1078
    • Optical neuropathy and Graves' disease

      ea0035p1079
    • Associations of thyroid function and autoantibodies with parameters of oxidative stress in women with Hashimoto's thyroiditis

      ea0035p1080
    • Involvement of Lat2 in the transport of 3,3[prime]-T2 across the plasma membrane and first structural insights into transport mechanisms by homology model generation

      ea0035p1081
    • A Sensitive LC/MS/MS Method for the Quantification of Free T3 and Free T4 in Serum, using a Simple Ultrafiltration Sample Preparation

      ea0035p1082
  • Thyroid Cancer
  • • Langerhans cell histiocytosis and papillary thyroid carcinoma

      ea0035p1083
    • Thyroid carcinoma in cases with end stage renal disease

      ea0035p1084
    • The deleterious effect of levothyroxine (T4) withdrawal on the degree of lipid profile change during follow-up of patients with differentiated thyroid cancer (DTC)

      ea0035p1085
    • Symptomatic hypercalcemia due to primary hyperparathyroidism by parathyroid carcinoma

      ea0035p1086
    • Incidence of thyroid microcarcinoma in relation to gender and age in non-toxic thyroid diseases treated with total thyroidectomy

      ea0035p1087
    • Estimated 10-year risk of bone fracture in women with diffentiated thyroid cancer on TSH-suppressive levo-thyroxine therapy

      ea0035p1088
    • Prognosis and outcome analysis of thyroid cancer: experience from a tertiary care centre in Pakistan

      ea0035p1089
    • Sentinel lymph node biopsy in thyroid papillary and medullary microcarcinomas

      ea0035p1090
    • Surgical treatment of papillary thyroid carcinoma in children and adolescents

      ea0035p1091
    • Correlation between biochemical and ultrasound parameters in patients with single parathyroid adenoma

      ea0035p1092
    • Atorvastatin medullar thyroid cancer over TT cell line impact of apoptosis and calcitonin over gene expression

      ea0035p1093
    • Anti-proliferative effects of evodiamine on human thyroid cancer cells

      ea0035p1094
    • Differential miRNAs expression in papillary thyroid cancer is associated with clinico-pathological features and BRAF mutation

      ea0035p1095
    • Ultrasound risk factors of thyroid cancer

      ea0035p1096
    • Do the poorly differentiated and undifferentiated thyroid carcinomas could be the next candidates to somatostatin analoques treatment?

      ea0035p1097
    • Risk factors of cancer relapse in differentiated thyroid carcinomas

      ea0035p1098
    • DNMT1 expression in papillary thyroid carcinoma

      ea0035p1099
    • Methylation status of HOXB4 gene in papillary thyroid carcinoma

      ea0035p1100
    • The influence of polymorphisms in tumor suppressor genes in thyroid carcinomas

      ea0035p1101
    • Familial medullary thyroid carcinomas: RET mutation in exon 8 is associated with better prognosis but increased risk for other malignancies

      ea0035p1102
    • Single nucleotide polymorphisms associated with papillary thyroid cancer

      ea0035p1103
    • A retrospective gender-comparative evaluation of differentiated thyroid cancers

      ea0035p1104
    • Nonincidentally and incidentally discovered thyroid cancer

      ea0035p1105
    • The role of DNA repair proteins in the assessment of thyroid nodules

      ea0035p1106
    • Effects of zoledronic acid monohydrate on cytotoxicity and apoptosis in BCPAP human papillary thyroid carcinoma cell line

      ea0035p1107
    • Morphology of recurrent papillary thyroid carcinoma

      ea0035p1108
    • Ca 19-9: is there a role for potential new biomarker for medullary thyroid cancer?

      ea0035p1109
    • Metastatic thyroid papillary microcarcinomas

      ea0035p1110
    • Prognostic implications of stage pT3 in well differentiated thyroid cancer

      ea0035p1111
    • The utility of ultrasonographic features on the accuracy of diagnosing individual types of thyroid malignancies

      ea0035p1112
    • Prognosis of papillary and follicular thyroid cancers with serum thyroglobulin antibody at 1 year after total thyroidectomy

      ea0035p1113
    • Increased mean platelet volume in papillary thyroid cancer

      ea0035p1114
    • Preoperative TSH value, does it predict the surgical findings in papillary thyroid cancer?

      ea0035p1115
    • Thyroglobulin measurements in fine-needle aspiration cytology of lymph nodes in patients after thyroidectomy because of differentiated thyroid cancer

      ea0035p1116
    • Prediction of lymph node metastasis in papillary thyroid cancer by preoperative BRAF analysis, is it useful?

      ea0035p1117
    • Clinical and biochemical characteristics of papillary thyroid cancer according to the presence of BRAF (V600E) mutation

      ea0035p1118
    • Survivin splice variants expression in thyroid malignancy

      ea0035p1119
    • Diffuse sclerosing variant of papillary thyroid carcinoma is a rare variant

      ea0035p1120
    • The role of microRNAs in regulation of RAR[beta] and its function in development of papillary thyroid carcinoma

      ea0035p1121
    • Rising serum thyroglobulin in the follow-up of patients with differentiated thyroid carcinoma: the role of FDG PET-CT

      ea0035p1122
    • Sodium-iodide symporter and its microRNA-dependent deregulation in papillary thyroid carcinoma.

      ea0035p1123
    • Functional analysis of newly discovered microRNA deregulated in papillary thyroid carcinoma

      ea0035p1124
    • Apical iodide transporter and its microRNA-induced silencing in thyroid malignancies

      ea0035p1125
    • TERT promoter mutations correlate with a more advanced stage at diagnosis and with a poorer prognosis in differentiated thyroid cancer

      ea0035p1126
    • Abstract unavailable

      ea0035p1127
    • Next-generation sequencing reveals a novel thyroglobulin-embedded microRNA gene deregulated in papillary thyroid carcinoma

      ea0035p1128
    • The role of ATM-CHEK2-BRCA1 axis in determination of genetic predisposition and clinical presentation of papillary thyroid carcinoma

      ea0035p1129
    • Evaluation of factors predict the efficacy of thyroid remnant ablation in patients with differentiated thyroid carcinoma

      ea0035p1130
    • The role of the transcription factor: Prospero homeobox 1: in the biology of differentiated thyroid cancer

      ea0035p1131
    • Treatment outcomes and prognosis of medullary thyroid carcinoma in a tertiary endocrinology center

      ea0035p1132
    • The presence of BRAFV600E mutation in patients diagnosed of papillary thyroid carcinoma in holycross cancer centre in Kielce, Poland

      ea0035p1133
    • Papillary thyroid microcarcinoma: focus on prevalence, characterization and follow-up during a 10 years time period

      ea0035p1134
    • The role of podoplanin in the biology of differentiated thyroid cancers

      ea0035p1135
    • Prevalence and risk of malignancy of thyroid incidentalomas discovered by 18F-fluorodeoxyglucose positron emission tomography

      ea0035p1136
    • Gardner syndrome; a case of presenting with agressive varyant papillary thyroide cancer

      ea0035p1137
    • Prognostic factors in 213 patients with differentiated thyroid cancer

      ea0035p1138
    • The effect of allelic variants of the thyroid hormone receptor [beta] (THRB) gene on the incidence of papillary thyroid carcinoma

      ea0035p1139
    • Thyroglobulin before radio remnant ablation during levothyroxine withdrawal can be considered an accurate parameter of remission of differentiated thyroid cancer

      ea0035p1140
    • The usefulness of thyroid function tests for the estimation of individual sensitivity to levothyroxine therapy in patients with thyroid cancer

      ea0035p1141
    • Polymorphic pre-miR-146a and synergistic action of all of its products on NTRK2 gene in papillary thyroid carcinoma

      ea0035p1142
    • Post-ablative thyroglobulin level as a predictor of favourable prognosis in patients with differentiated thyroid cancer

      ea0035p1143
    • Coexistence of mutations in the CHEK2 and BRAFV600E genes and their impact on the course of the papillary thyroid carcinoma (PTC)

      ea0035p1144
    • Impact of different methods on the detection frequency of BRAF mutation in papillary thyroid carcinoma

      ea0035p1145
    • Long-term follow-up of young patients submitted to radiotherapy: analysis of ten thyroid cancer cases

      ea0035p1146
    • Occurrence other than V600E mutation in the BRAF gene in papillary thyroid carcinoma

      ea0035p1147
    • Does lymphocytic thyroiditis influence the histological characteristics and the course of thyroid carcinoma in children and adolescents?

      ea0035p1148
    • Prognostic significance of TERT promoter mutations in follicular cell-derived thyroid carcinomas

      ea0035p1149
    • BRAF V600E genetic mutation analysis in patients had been diagnosed of unknown malignancy potential thyroid tumors and papillary thyroid microcarcinoma

      ea0035p1150
    • Prognosis of papillary thyroid cancer with lung metastasis at diagnosis

      ea0035p1151
    • Gene expression signature associated with BRAFV600E mutation in human papillary thyroid carcinoma based on transgenic mouse model

      ea0035p1152